Doç. Dr. ABDULSAMET ERDEN

Yayın Ağı

Makaleler 246

1. Assessment of interstitial lung disease in systemic sclerosis using oscillometric methods: a novel approach to respiratory assessment

Vasi İ., Karaduman İ., Alacaoğlu Ş., Duygulu S., Kardaş R. C., Yıldırım D., et al.

RHEUMATOLOGY , 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

2. Investigation of the pathogenic variants induced Sjogren's syndrome in Turkish population.

Terzi U., Ates I., Erden A., Suzen S., Irham L. M., Yilmaz S.

Open medicine (Warsaw, Poland) , cilt.20, sa.1, ss.20251294, 2025 (SCI-Expanded, Scopus)

3. Between diffuse and limited: the unique identity of systemic sclerosis–overlap syndromes

KÜÇÜK H., VASİ İ., KARADUMAN İ., ERDEN A.

Anatolian Current Medical Journal , cilt.7, sa.6, ss.913-918, 2025 (TRDizin)

4. Lupus and IgA nephropathy: coexistence or coincident?

Duran R., Yıldırım D., Can Kardaş R., Vasi İ., Kaya B., Çakır Y., et al.

Wiener klinische Wochenschrift , cilt.137, sa.19-20, ss.628-634, 2025 (SCI-Expanded, Scopus)

5. Unfolding dermatological spectrum of Still's disease: a cohort study from the International AIDA Network Still's Disease Registry.

Calabrese L., D'Onghia M., Cartocci A., Hinojosa-Azaola A., Torres-Ruiz J., Lopalco G., et al.

Rheumatology (Oxford, England) , 2025 (SCI-Expanded, Scopus)

6. Vascular calcification in Takayasu arteritis: relationship with metabolic syndrome, left ventricular mass index, and intima-media thickness

Karadeniz H., Kesen S., Akhan M. B., Unlu S., Kardas R. C., Guler A. A., et al.

HELLENIC JOURNAL OF CARDIOLOGY , cilt.85, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

7. A new characteristıc of systemic lupus erythematosus: subclinical vein involvement-an in-depth biochemical and imaging study.

Yildirim D., Erden A., Ibrahimkhanli N., Elefante E., Duran R., Kanik H. K., et al.

Rheumatology (Oxford, England) , 2025 (SCI-Expanded, Scopus)

8. Evolution of Clinical Characteristics and Treatment Strategies in Turkish SLE Patients Over Two Decades: A Retrospective Cohort Study

Kanik H. K., ERDEN A., Yildirim D., Kanik A. B., DURAN R., Kardas R. C., et al.

BRATISLAVA MEDICAL JOURNAL , cilt.126, sa.9, ss.2329-2336, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

9. Importance of potential prothrombotic state markers in Behçet's disease and correlation with vascular ultrasound.

Karadeniz H., Mammadov T., Cerit M. N., Kardas R. C., Guler A. A., Yıldırım D., et al.

Irish journal of medical science , cilt.194, sa.4, ss.1525-1532, 2025 (SCI-Expanded, Scopus)

10. Refractory Nodular Scleritis as a Presenting Sign of Colorectal Cancer

Duran R., Kıran Y., Özdemir Yalçınsoy K., Bölek E. Ç., Erden A.

OCULAR IMMUNOLOGY AND INFLAMMATION , cilt.33, sa.7, ss.1479-1482, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

11. The relationship between disease activity, quality of life, and psychological status in patients with rheumatoid arthritis: A cross-sectional study

KARAKAŞ Ö., Ağır M., ERDEN A.

Ulusal Romatoloji Dergisi , cilt.17, sa.2, ss.85-91, 2025 (Scopus, TRDizin)

12. Choroidopathy in patients with systemic lupus erythematosus using enhanced depth imaging spectral domain optical coherence tomography and optical coherence tomography angiography

Bayuk E. G., Doguizi S., ERTEN Ş., Karakas O., Ozdal P. C.

INTERNATIONAL JOURNAL OF OPHTHALMOLOGY , cilt.18, sa.6, ss.1053-1063, 2025 (SCI-Expanded, Scopus)

13. Is Myopenia or Myosteatosis Clinically Relevant in Systemic Sclerosis? Skeletal Muscle Assessment Using Computed Tomography

Kılıç A. C., Vasi İ., Kılıç H. K., Erden A., Gündoğdu O., Kardaş R. C., et al.

ACADEMIC RADIOLOGY , cilt.32, sa.6, ss.3574-3584, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

14. Validity and reliability of the Turkish version of "The Occupational Circumstances Assessment Interview and Rating Scale" in rheumatic diseases

AKYÜREK G., BUMİN G., Onal G., Unal B., GÖKMEN D., ERDEN A., et al.

BRITISH JOURNAL OF OCCUPATIONAL THERAPY , cilt.88, sa.6, ss.344-351, 2025 (SCI-Expanded, SSCI, Scopus)

15. PRDX-4: a novel biomarker similar to KL-6 for predicting the occurrence and progression of systemic sclerosis-ILD.

Alp G. T., Vasi İ., Alp E., Güler A. A., Karadeniz H., Gülbahar Ö., et al.

Biomarkers in medicine , cilt.19, sa.9, ss.349-355, 2025 (SCI-Expanded, Scopus)

16. Serum Semaphorin 3A Levels in Patients with Behçet’s Disease with and without Vascular Involvement

Kayaalp M. Ç., ERDEN A., Karakaş Ö., Güven S. C., Armağan B., Kayaalp M., et al.

Bratislava Medical Journal , cilt.126, sa.5, ss.767-776, 2025 (SCI-Expanded, Scopus)

17. Is IgG4-Related Disease a Potential Risk Factor for Multiple Malignancies?

Duran R., Yıldırım D., Kardaş R. C., Vasi İ., Küçük H., Erden A.

International journal of rheumatic diseases , cilt.28, sa.5, 2025 (SCI-Expanded, Scopus)

18. Real-World Insights From Türkiye: Biologic DMARDs Usage in Spondyloarthritis Patients With Chronic Kidney Disease.

Bulut Gökten D., Tezcan M. E., Yağız B., Erden A., Kimyon G., Yaşar Bilge N. Ş., et al.

International journal of rheumatic diseases , cilt.28, sa.5, 2025 (SCI-Expanded, Scopus)

19. Predicting extra-musculoskeletal and peripheral manifestations and their role on biologic treatment in patients with axial spondyloarthritis: TReasure experience

Durak Ediboglu E., KALYONCU U., Solmaz D., YAŞAR BİLGE N. Ş., Yılmaz S., Bes C., et al.

Archives of Rheumatology , cilt.40, sa.1, ss.1-14, 2025 (SCI-Expanded, Scopus, TRDizin)

20. Serum CXCL-13 levels are associated with active neurological involvement in patients with systemic lupus erythematosus.

Yildirim D., Erden A., Fanouriakis A., Koc Kanik H., Babaoglu H., Kardas R. C., et al.

Lupus , cilt.34, sa.3, ss.281-291, 2025 (SCI-Expanded, Scopus)

21. From Conventional to Advanced Therapies: A National Health Registry Report (2016-2022) on DMARDs in Rheumatoid Arthritis Treatment in Turkey

Ata N., Satis H., KÜÇÜKŞAHİN O., KARABULUT E., Ayan G., ERDEN A., et al.

BIOLOGICS-TARGETS & THERAPY , cilt.19, ss.331-339, 2025 (ESCI, Scopus)

22. Intersecting Pathways: Moyamoya Syndrome and Antiphospholipid Antibodies—A Comprehensive Review of Clinical Insights, Therapeutic Considerations and Prospective Perspectives

VASİ İ., KARDAŞ R. C., TALAY K., YILDIRIM D., KAYA B., DURAN R., et al.

Acta Neurologica Scandinavica , cilt.2025, sa.1, 2025 (SCI-Expanded, Scopus)

23. Behçet's disease beyond the criteria: insights from a tertiary centre in Turkey.

Firlatan Yazgan B., Sahin Mavi E. A., Kart Bayram G. S., Bulat B., Ekici M., Unaldi E., et al.

Clinical and experimental rheumatology , cilt.43, ss.1782-1788, 2025 (SCI-Expanded, Scopus)

24. Prevalence, incidence and geographic distribution of familial Mediterranean fever in Turkey: a national cohort study.

Satiş H., Gül A., Ayan G., Babaoğlu H., Armağan B., Erden A., et al.

Clinical and experimental rheumatology , cilt.43, ss.1709-1714, 2025 (SCI-Expanded, Scopus)

25. COVID-19 or systemic lupus erythematosus: Attention to similarity

ERDEN A., Karakas O., Ulusoy B. O., Gemcioglu E., İZDEŞ S., Guner R., et al.

REVISTA ROMANA DE MEDICINA DE LABORATOR , cilt.33, sa.1, ss.59-64, 2025 (SCI-Expanded)

26. Obstruktif Uyku Apne Sendromu Tanılı Hastalarda Hematolojik Parametrelerin Değerlendirilmesi; Tek Merkez Deneyimi

USLU E., ERDEN A., BOL O., karagöz h.

Journal of Anatolian Medical Research , cilt.9, sa.3, ss.102-106, 2024 (Hakemli Dergi)

27. TOFACITINIB: CURRENT CONSIDERATIONS IN THE MANAGEMENT OF IMMUNE INFLAMMATORY DISORDERS

Erden A.

Rheumatology Quarterly , cilt.2, sa.4, ss.158-162, 2024 (Hakemli Dergi)

28. Is the visceral adiposity index associated with the presence of cardiovascular risk scores and comorbidity in psoriatic disease?

OMMA A., ERDEN F., ÇOLAK S., Can Sandıkçı S., OMMA T., KASIM İ., et al.

Ulusal Romatoloji Dergisi , cilt.16, sa.3, ss.90-96, 2024 (TRDizin)

29. Nationwide study on the prevalence of rheumatoid factor and anticitrullinated peptide positivity and their contribution to rheumatoid arthritis diagnosis.

Satiş H., Erden A., Bilgin E., Ayan G., Armağan B., Tecer D., et al.

Turkish journal of medical sciences , cilt.54, sa.5, ss.949-955, 2024 (SCI-Expanded, Scopus, TRDizin)

30. Assessment of venous disease with different venous disease specific scales in Behçet's disease patients with deep vein thrombosis.

Aksoy A., Colak S., Yagiz B., Coskun B. N., Omma A., Sarı A., et al.

Phlebology , cilt.39, sa.8, ss.550-556, 2024 (SCI-Expanded, Scopus)

31. Kolorektal kanserli hastaların demografik özellikleri

KARAKAŞ Ö., ERDEN A., aydın isak ö., İMAMOĞLU G. İ., KAYHAN S.

Turkish Journal of Clinics and Laboratory , cilt.15, sa.3, ss.376-382, 2024 (TRDizin)

32. Baseline capillaroscopy provides no evidence of microvascular changes to predict long-COVID syndrome.

Ulusoy B. O., Babaoglu H., Aypak B. A. A., Akinci E., Kucuksahin O., Erten A. O. S., et al.

Bratislavske lekarske listy , 2024 (SCI-Expanded, Scopus)

33. Calcineurin inhibitors in unplanned pregnancies with active lupus disease: A retrospective observational study.

Vasi İ., Yıldırım D., Kardaş R. C., Kaya B., Duran R., Alp G. T., et al.

International journal of clinical pharmacology and therapeutics , cilt.62, sa.7, ss.326-333, 2024 (SCI-Expanded, Scopus)

34. Unveiling cancer risk in ANCA-associated vasculitis: result from the Turkish Vasculitis Study Group (TRVaS).

Bilgin E., Demirci Yıldırım T., Özdemir Ulusoy B., Öğüt T. S., Karabacak M., Sadioğlu Çağdaş Ö., et al.

Internal and emergency medicine , cilt.19, sa.4, ss.1025-1034, 2024 (SCI-Expanded, Scopus)

35. Assessment and comparison of the 2023 ACR/EULAR APS criteria with the revised Sapporo criteria.

Vasi İ., Kardaş R. C., Ekici M., Yıldırım D., Kaya B., Duran R., et al.

International journal of rheumatic diseases , cilt.27, sa.5, 2024 (SCI-Expanded, Scopus)

36. Coronavirus Disease 2019 Outcomes in Amyloid A Protein Amyloidosis Secondary to Rheumatic Conditions and Signs of Post- Coronavirus Disease 2019 Proteinuria Progression.

Güven S. C., Erden A., Küçük H., Apaydın H., Polat B., Kardaş R. C., et al.

European journal of rheumatology , cilt.11, sa.1, ss.2-7, 2024 (ESCI, TRDizin)

37. The burden of face affected questionnaire in patients with systemic sclerosis: Translation, cross-cultural adaptation and psychometric properties in the Turkish version

Sari F., Apaydin Z. B., Apaydin H. A., Kayaalp M., ERDEN A., Güven S. C., et al.

Egyptian Rheumatologist , cilt.46, sa.2, ss.56-61, 2024 (ESCI, Scopus)

38. Non-criteria autoantibodies in antiphospholipid syndrome may be associated with underlying disease activity.

Akyüz Dağlı P., Erden A., Babaoğlu H., Karakaş Ö., Özdemir Ulusoy B., Konak H. E., et al.

Irish journal of medical science , cilt.193, sa.2, ss.1099-1107, 2024 (SCI-Expanded, Scopus)

39. Low relapse rate in patients with giant cell arteritis in a multi-centre retrospective Turkish Registry.

Alibaz-Öner F., Kelesoglu B., Balci M. A., Yardimci G. K., Armağan B., Kiliç L., et al.

Clinical and experimental rheumatology , cilt.42, sa.4, ss.816-821, 2024 (SCI-Expanded, Scopus)

40. Reliability and validity of the Turkish version of Scleroderma Skin Patient-Reported Outcome in patients with systemic sclerosis

Sari F., Bazancir Apaydin Z., Apaydin H., Kayaalp M., ERDEN A., Güven S. C., et al.

Archives of Rheumatology , cilt.39, sa.1, ss.52-59, 2024 (SCI-Expanded, Scopus, TRDizin)

41. Colchicine-intolerant familial mediterranean fever patients: A comparative study between different colchicine doses and IL-1 inhibitor monotherapy.

Yildirim D., Kardas R. C., Gun M., Kaya B., Vasi I., Duran R., et al.

International immunopharmacology , cilt.128, ss.111491, 2024 (SCI-Expanded, Scopus)

42. Is compressed colchicine tablet superior to other colchicine preparations in patients with familial Mediterranean fever?

Vasi İ., Kardaş R. C., Yıldırım D., Kaya B., Duran R., Karadeniz H., et al.

INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS , cilt.62, ss.77-82, 2024 (SCI-Expanded, Scopus)

43. Tocilizumab as a first line biologic agent in rheumatoid arthritis patients with inadequate response to disease-modifying anti-rheumatic drugs: real life experience from the TReasure Registry.

Karadag O., Farisogullari B., Yagiz B., Erden A., Ademoglu Z., Kimyon G., et al.

Clinical and experimental rheumatology , cilt.42, ss.130-137, 2024 (SCI-Expanded, Scopus)

44. Clinical characteristics and disease course before and after SARS-CoV-2 infection in a large cohort of systemic sclerosis patients.

AVANOĞLU GÜLER A., ÖZÇİMEN B., Aydoğdu M. S., Sari A., Numune A., TÜZÜN ERSAN N., et al.

Turkish journal of medical sciences , cilt.54, sa.1, ss.76-85, 2023 (SCI-Expanded, Scopus, TRDizin)

45. The predictors of paradoxical reactions especially psoriasis with biologic therapy from the TReasure database: a 5-year follow-up study.

Yagiz B., Lermi N., Coskun B. N., Dalkilic E., Kiraz S., Erden A., et al.

Rheumatology (Oxford, England) , cilt.62, ss.3962-3967, 2023 (SCI-Expanded, Scopus)

46. Semaphorin 3A levels in vascular and nonvascular phenotypes in systemic sclerosis.

Kayaalp M., Erden A., Apaydin H., Güven S. C., Armağan B., Cağlayan Kayaalp M., et al.

Laboratory medicine , cilt.54, ss.646-651, 2023 (SCI-Expanded, Scopus)

47. Diffuse generalized venulitis as the primary pathology of Behçet's disease: A comprehensive magnetic resonance venography study.

Karadeniz H., Ucar M., Mammadov T., Mirzayeva L. S., Guler A. A., Kardas R. C., et al.

Seminars in arthritis and rheumatism , cilt.62, ss.152246, 2023 (SCI-Expanded, Scopus)

48. Could serum HMGB1 levels be a predictor associated with psoriatic arthritis?

Yildirim D., Baykul M., Edek Y. C., Gulengul M., Alp G. T., Eroglu F. S., et al.

BIOMARKERS IN MEDICINE , cilt.17, sa.20, ss.871-880, 2023 (SCI-Expanded, Scopus)

49. HCV-related cryoglobulinemic vasculitis/Cryoglobulinemic vasculitis: Definition based on Chapel Hill Conference Consensus 2012 and case report

ÖZDEMİR B., ERDEN A.

Acta Medica , cilt.54, sa.1, ss.46-49, 2023 (TRDizin)

50. Epidemiological characteristics of hepatitis B and C in patients with inflammatory arthritis: Implications from treasure database

Ersözlü E. D., EKİCİ M., COŞKUN B. N., Badak S. Ö., BİLGİN E., KALYONCU U., et al.

Archives of Rheumatology , cilt.38, sa.3, ss.347-357, 2023 (SCI-Expanded, Scopus, TRDizin)

51. The outcome of COVID-19 in patients with autoimmune rheumatic diseases: Comparable to the general population or worse?

Batu E. D., Erden A.

International journal of rheumatic diseases , cilt.26, sa.8, ss.1435-1439, 2023 (SCI-Expanded, Scopus)

52. Long-Term Results of Immunogenicity of Booster Vaccination against SARS-CoV-2 (Hybrid COV-RAPEL TR Study) in Turkiye: A Double-Blind, Randomized, Controlled, Multicenter Phase 2 Clinical Study.

Ates I., Batirel A., Aydin M., Karadag F. Y., Erden A., Kucuksahin O., et al.

Vaccines , cilt.11, sa.7, 2023 (SCI-Expanded, Scopus)

53. Serum triggering receptor expressed on myeloid cells-1 (TREM-1) levels may be associated with disease activity in patients with familial Mediterranean fever

YILDIRIM D., avcu a., erdoğan e., ERDEN A., KÜÇÜK H.

Ulusal Romatoloji Dergisi , cilt.15, sa.2, ss.67-72, 2023 (Scopus, TRDizin)

54. Sonoelastography and S100 proteins in the differential diagnosis of IgG4-related disease (IgG4-RD)

Karadeniz H., Yılmaz Demirci N., Cerit M. N., Allahverdiyeva S., Paşaoğlu H., Karaoğlan A., et al.

Ulusal Romatoloji Dergisi , cilt.15, sa.2, ss.73-81, 2023 (Scopus, TRDizin)

55. Rituximab use may indicate impaired quality of life in granulomatosis with polyangiitis

AKYÜZ DAĞLI P., GÜVEN S. C., ERDEN A., eskin M. A., ARMAĞAN B., KÜÇÜKŞAHİN O., et al.

Ulusal Romatoloji Dergisi , cilt.15, sa.2, ss.53-59, 2023 (Scopus, TRDizin)

56. AB1162 COMPARISON OF SERUM CXCL13 LEVELS BETWEEN PATIENTS WITH PSORIASIS AND PSORIATIC ARTHRITIS

Yildirim D., Vasi I., Baykul M., Gulengul M., Edek Y. C., Küçük H., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.82, ss.1811-1812, 2023 (SCI-Expanded, Scopus)

57. COVID-19 disease frequency, risk factors, and re-infection rates in patients with autoimmune rheumatic disease receiving rituximab.

Armağan B., Konak H. E., Özdemir B., Apaydın H., Atalar E., Akyüz Dağlı P., et al.

International journal of rheumatic diseases , cilt.26, sa.5, ss.930-937, 2023 (SCI-Expanded, Scopus)

58. Clinical and laboratory factors associated with the bamboo spine in patients with axial spondyloarthritis: are there clues for the bamboo spine?

Atagündüz P., Kiraz S., Akar S., Küçükşahin O., Erden A., Aksoy A., et al.

Clinical and experimental rheumatology , cilt.41, ss.620-627, 2023 (SCI-Expanded, Scopus)

59. Evaluation of patients with antiphospholipid syndrome subsequently COVID-19 vaccinations: A retrospective cohort study

Karakaş Ö., Erden A., Armağan B., Güven S. C., Atalar E., Polat B., et al.

International Journal of Rheumatic Diseases , cilt.26, sa.2, ss.292-297, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

60. Mortality in psoriatic arthritis patients, changes over time, and the impact of COVID-19: results from a multicenter Psoriatic Arthritis Registry (PsART-ID).

Erden A., Ayan G., Kilic L., Solmaz D., Bakirci S., Kimyon G., et al.

Clinical rheumatology , cilt.42, ss.385-390, 2023 (SCI-Expanded, Scopus)

61. EFFICACY AND SAFETY OF TOFACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS

Bayram D., ERDEN A., kart bayram g. s., BAŞER S., ERTEN Ş.

Middle Black Sea Journal of Health Science , cilt.9, sa.1, ss.50, 2023 (Hakemli Dergi)

62. Tofacitinib experience in patients with enteropathic arthritis.

Dağlı P. A., Erden A., Güven S. C., Armağan B., Yürekli Ö. T., Özin Y. Ö., et al.

Immunotherapy , cilt.15, ss.619-626, 2023 (SCI-Expanded, Scopus)

63. A SINGLE-CENTER RHEUMATOLOGY EXPERIENCE OF SARCOIDOSIS: OBSERVATIONS FROM 70 PATIENTS

Konak H. E., Guven S. C., Atalar E., Dagli P. A., Ulucakoy R., Erdogan E. K., et al.

SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES , cilt.40, sa.3, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

64. Pulmonary hypertension in Behçet’s disease: echocardiographic screening and multidisciplinary approach

Armağan B., Okşul M., ŞENER Y. Z., Sari A., Erden A., Yardimci G. K., et al.

Turkish Journal of Medical Sciences , cilt.53, sa.2, ss.563-571, 2023 (SCI-Expanded, Scopus, TRDizin)

65. The impact of antiphospholipid antibodies in Takayasu arteritis

Firat Şentürk E., Erden A., Sari A., Armağan B., KILIÇ L., KALYONCU U., et al.

Turkish Journal of Medical Sciences , cilt.53, sa.1, ss.199-205, 2023 (SCI-Expanded, Scopus, TRDizin)

66. Derivation and validation of adult Still Activity Score (SAS)

Kalyoncu U., Kasifoglu T., Omma A., Bes C., Cinar M., Emmungil H., et al.

Joint Bone Spine , cilt.90, sa.1, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

67. The Possible Relation of Demodex and Facial Erythema in Connective Tissue Diseases

Erden A., Armağan B., Güven S. C., Karakaş Ö., Erden F., Özdemir B., et al.

Iranian Journal of Parasitology , cilt.18, sa.2, ss.237-243, 2023 (SCI-Expanded, Scopus)

68. Effects of sulfasalazine in axial spondyloarthritis on COVID-19 outcomes: real-life data from a single center

Armağan B., Atalar E., Güven S. C., Özdemir B., Konak H. E., Akyüz Dağlı P., et al.

Immunopharmacology and Immunotoxicology , cilt.45, sa.4, ss.395-401, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

69. Ustekinumab in enteropathic arthritis.

Ulusoy B. Ö., Erden A., Güven S. C., Armağan B., Yürekli Ö. T., Özin Y. Ö., et al.

Immunotherapy , cilt.15, ss.583-592, 2023 (SCI-Expanded, Scopus)

70. Effects of breast milk on Behçet’s disease clinical features

Konak H. E., Erden A., Armağan B., Güven S. C., Apaydin H., Dağli P. A., et al.

Turkish Journal of Medical Sciences , cilt.53, sa.1, ss.121-129, 2023 (SCI-Expanded, Scopus, TRDizin)

71. Restless leg syndrome and sleep quality in granulomatosis with polyangiitis

GÜVEN S. C., AKYÜZ DAĞLI P., Karacaoğlu S., ARMAĞAN B., ERDEN A., KÜÇÜKŞAHİN O., et al.

Ulusal Romatoloji Dergisi , cilt.14, sa.3, ss.124-130, 2022 (Scopus, TRDizin)

72. Effects of COVID-19 on axial spondyloarthritis disease flare

ARMAĞAN B., ATALAR E., ÖZDEMİR B., KARAKAŞ Ö., KAYACAN ERDOĞAN E., GÜVEN S. C., et al.

GULHANE MEDICAL JOURNAL , cilt.64, ss.301-306, 2022 (Scopus, TRDizin) Sürdürülebilir Kalkınma

73. Effectiveness and safety of tofacitinib in rheumatoid arthritis-associated interstitial lung disease: TReasure real-life data

KALYONCU U., BİLGİN E., Erden A., SATIŞ H., TUFAN A., Tekgöz E., et al.

Clinical and Experimental Rheumatology , cilt.40, sa.11, ss.2071-2077, 2022 (SCI-Expanded, Scopus)

74. Tuberculin skin test before biologic and targeted therapies: does the same rule apply for all?

İlgen U., KARADAĞ Ö., EMMUNGİL H., KÜÇÜKŞAHİN O., Koca S. S., Erden A., et al.

Rheumatology International , cilt.42, sa.10, ss.1797-1806, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

75. Recurrent Aphthous Stomatitis and Related Factors in Turkish Adult Population: A Striking Outcome of Cappadocia Chronic Diseases Epidemiological Study

ÇALIK BAŞARAN N., KALYONCU U., KARADAĞ Ö., AKDOĞAN A., ERDEN A., KILIÇ L., et al.

Cumhuriyet Tıp Dergisi (ELEKTRONİK) , cilt.44, sa.3, ss.233-238, 2022 (Hakemli Dergi)

76. Effects of anti-SARS-CoV-2 vaccination on safety and disease exacerbation in patients with Behçet syndrome in a monocentric cohort

Apaydin H., Erden A., Güven S. C., Armağan B., Konak H. E., Polat B., et al.

International Journal of Rheumatic Diseases , cilt.25, sa.9, ss.1068-1077, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

77. Performance of the systemic lupus erythematosus risk probability index in a cohort of undifferentiated connective tissue disease

Erden A., Apaydın H., Fanouriakis A., Güven S. C., Armagan B., Akyüz Dağlı P., et al.

Rheumatology (Oxford, England) , cilt.61, sa.9, ss.3606-3613, 2022 (SCI-Expanded, Scopus)

78. Clinical course of idiopathic inflammatory myopathies in the COVID-19 pandemic: a single-center experience

Apaydin H., Erden A., Güven S. C., Armağan B., Karakaş Ö., Özdemir B., et al.

Future Virology , cilt.17, sa.8, ss.545-556, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

79. A single-center COVID-19 vaccine experience with CoronaVac and BNT162b2 in familial Mediterranean fever patients

Güven S. C., Karakaş Ö., Atalar E., Konak H. E., Akyüz Dağlı P., Kayacan Erdoğan E., et al.

International Journal of Rheumatic Diseases , cilt.25, sa.7, ss.787-794, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

80. Metabolic syndrome is associated with increased cardiovascular risk and disease damage in patients with Takayasu arteritis

Sağlam B., Kaymaz-Tahra S., Kenar G., Kocaer S., Omma A., Erden A., et al.

International Journal of Rheumatic Diseases , cilt.25, sa.7, ss.775-780, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

81. Intravenous Treatment Adherence of Patients with Chronic Inflammatory Rheumatic Diseases During the COVID-19 Pandemic: Experience of a Single Center

Konak H. E., ARMAĞAN B., GÜVEN S. C., ATALAR E., KARAKAŞ Ö., ESMER S., et al.

ROMANIAN JOURNAL OF INTERNAL MEDICINE = REVUE ROUMAINE DE MEDECINE INTERNE , cilt.0, 2022 (ESCI, Scopus) Sürdürülebilir Kalkınma

82. PARADOXICAL REACTIONS, ESPECIALLY PSORIASIS IN RHEUMATOLOGY PATIENTS RECEIVING BIOLOGIC THERAPY FROM THE TREASURE DATABASE: A 5-YEAR FOLLOW-UP STUDY

Yagiz B., Lermi N., COŞKUN N., DALKILIÇ H. E., Kiraz S., Ertenli A. I., et al.

ANNALS OF THE RHEUMATIC DISEASES , cilt.81, ss.1513-1514, 2022 (SCI-Expanded, Scopus)

83. Semaphorin 3A Levels in Lupus with and without Secondary Antiphospholipid Antibody Syndrome and Renal Involvement

Bayram G. S. K., Erden A., Bayram D., Özdemir B., Karakaş Ö., Apaydln H., et al.

Lab Medicine , cilt.53, sa.3, ss.285-289, 2022 (SCI-Expanded, Scopus)

84. Comprehensive assessment and outcomes of patients with chronic periaortitis

Yardimci G., Düzgün S. A., Farisogullari B., Bolek E. Ç., ELDEM F. G., Erden A., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.40, sa.4, ss.801-810, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

85. Secukinumab in the treatment of psoriatic arthritis or ankylosing spondyloarthritis with multiple sclerosis: A case series with literature review

Eksin M. A., Erden A., Güven S. C., Armagan B., Ozdemir B., Karakas O., et al.

Immunotherapy , cilt.14, sa.6, ss.401-408, 2022 (SCI-Expanded, Scopus)

86. Antineutrophil cytoplasmic antibody positivity and clinical implications in COVID-19

Güven S. C., Apaydln H., Özdemir B., Armaǧan B., Ateş I., Erden A., et al.

Future Virology , cilt.17, sa.4, ss.239-245, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

87. Evaluation of Coronavirus Disease-2019 Patients with Nailfold Capillaroscopy

ARMAĞAN B., ÖZDEMİR B., AYPAK A., AKINCI E., KARAKAŞ Ö., GÜVEN S. C., et al.

Namık Kemal Medical Journal , cilt.10, sa.1, ss.80-86, 2022 (TRDizin) Sürdürülebilir Kalkınma

88. Physicians' Biological Drug Preference in Patients with Rheumatoid Arthritis and Spondyloarthritis with a History of Malignancy: Perspectives from the Treasure Database

Tekgoz E., Colak S., Yardimci K. G., KÜÇÜKŞAHİN O., Cinar M., Yilmaz S., et al.

Journal of Clinical Rheumatology , cilt.28, sa.2, 2022 (SCI-Expanded, Scopus)

89. COVID-19 in patients with Behçet's disease: Outcomes and rate of Behçet's exacerbations in a retrospective cohort

Polat B., Erden A., Güven S. C., Armaǧan B., Karakaş Ö., Özdemir B., et al.

Modern Rheumatology , cilt.32, sa.2, ss.455-459, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

90. The clinical significance of antiphospholipid antibodies in COVID-19 infection

Atalar E., Erden A., Guven S. C., Armagan B., Ates İ., KÜÇÜKŞAHİN O., et al.

Journal of Infection in Developing Countries , cilt.16, sa.2, ss.276-282, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

91. Comparison of APACHE II scores and mortality with CRP/albumin, neutrophil/lymphocyte and thrombocyte/lymphocyte ratios in patients admitted to internal medicine and anesthesia reanimation intensive care unit

Usta A., Gemcioglu E., Baser S., Ersoy O., Polat Y. H., Erden A., et al.

Journal of Laboratory Medicine , cilt.46, sa.1, ss.23-31, 2022 (Scopus) Sürdürülebilir Kalkınma

92. Pregnancy in Takayasu’s arteritis has a high risk of hypertension-related fetomaternal complications: A retrospective study of a Turkish cohort

Gönenli M. G., Kaymaz Tahra S., Kara M., Keser G., YAZICI A., Erden A., et al.

International Journal of Rheumatic Diseases , cilt.25, sa.2, ss.140-146, 2022 (SCI-Expanded, Scopus)

93. Hydroxychloroquine shortened hospital stay and reduced intensive care unit admissions in hospitalized COVID-19 patients

Omma A., Erden A., Apaydin H., Aslan M., Çamli H., Şahiner E. S., et al.

Journal of Infection in Developing Countries , cilt.16, sa.1, ss.25-31, 2022 (SCI-Expanded, Scopus)

94. Reducing length of hospital stay with colchicines

Karakaş Ö., Erden A., Güven S. C., Armaǧan B., Sahiner E. S., Kurtipek A. C., et al.

Journal of Infection in Developing Countries , cilt.16, sa.1, ss.57-62, 2022 (SCI-Expanded, Scopus)

95. COVID-19 course in granulomatosis with polyangiitis: single center experience with review of the literature

Armağan B., Eksin M. A., Güven S. C., Özdemir B., Akyüz Dağli P., KÜÇÜKŞAHİN O., et al.

Turkish Journal of Medical Sciences , cilt.52, sa.4, ss.899-909, 2022 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

96. Comparison of anakinra and tocilizumab in management of severe COVID-19: a retrospective cohort study

KÜÇÜKŞAHİN O., Erden A., Karakaş Ö., Güven S. C., Armağan B., Şahiner E. S., et al.

Turkish Journal of Medical Sciences , cilt.52, sa.5, ss.1486-1494, 2022 (SCI-Expanded, Scopus, TRDizin)

97. Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Türkiye: A randomized trial

Omma A., Batirel A., Aydin M., Yilmaz Karadag F., Erden A., KÜÇÜKŞAHİN O., et al.

Human Vaccines and Immunotherapeutics , cilt.18, sa.6, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

98. COVID-19 outcomes in patients with antiphospholipid syndrome: a retrospective cohort study

Erden A., Karakas O., Armagan B., Guven S., Ozdemir B., Atalar E., et al.

Bratislava Medical Journal , cilt.123, sa.2, ss.120-124, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

99. Budd-Chiari syndrome in Behcet's disease: a retrospective multicenter study

Akyol L., Toz B., Bayindir O., Zengin O., Cansu D., Yigit M., et al.

CLINICAL RHEUMATOLOGY , cilt.41, sa.1, ss.177-186, 2022 (SCI-Expanded, Scopus)

100. An evaluation of the results of convalescent plasma therapy applied to pregnant women diagnosed as COVID-19-positive in a pandemic center: A prospective cohort study

Erol S. A., Tanaçan A., Apaydin H., Göncü Ayhan Ş., Oluklu D., Uyan Hendem D., et al.

Turkish Journal of Medical Sciences , cilt.52, sa.3, ss.554-564, 2022 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

101. Brescia-COVID Respiratory Severity Scale (BRCSS) and Quick SOFA (qSOFA) score are most useful in showing severity in COVID-19 patients

San I., Gemcioglu E., BAŞER S., Yilmaz Cakmak N., Erden A., İZDEŞ S., et al.

Scientific Reports , cilt.11, sa.1, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

102. Should timing be considered before abandoning convalescent plasma in covid-19? Results from the Turkish experience

Ateş İ., Erden A., Güven S. C., Gürler E. K., Çağlayan A., Güçbey Ö., et al.

Transfusion and Apheresis Science , cilt.60, sa.6, 2021 (SCI-Expanded, Scopus)

103. COVID-19-Associated Cerebral Venous Sinus Thrombosis: A Case Report and Review of the Literature

AYPAK A., AKINCI E., ERDEN A., Çakır Topçu B., KÜÇÜKŞAHİN O., GÜNER H. R.

Mediterranean Journal of Infection, Microbes and Antimicrobials , cilt.10, sa.63, 2021 (Scopus) Sürdürülebilir Kalkınma

104. Endocan: A Novel Marker for Colchicine Resistance in Familial Mediterranean Fever Patients?

Omma A., Armaǧan B., Güven S. C., Sandıkçı S. C., Çolak S., Yücel Ç., et al.

Frontiers in Pediatrics , cilt.9, 2021 (SCI-Expanded, Scopus)

105. In the era of disease-modifying antirheumatic drugs, how close are we to treating rheumatoid arthritis without the use of glucocorticoids?

YAĞIZ B., COŞKUN B. N., PEHLİVAN Y., DALKILIÇ H. E., KİRAZ S., YAZISIZ V., et al.

RHEUMATOLOGY INTERNATIONAL , cilt.41, sa.11, ss.1915-1924, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

106. Compliance to not only prone but also lateral and supine positioning improves outcome in hospitalised COVID-19 patients

Ateş İ., Erden A., Gürler E. K., Çağlayan A., Güçbey Ö., Karakaş Ö., et al.

International Journal of Clinical Practice , cilt.75, sa.11, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

107. Predictors for the risk and severity of post-thrombotic syndrome in vascular Behcet's disease

AKSOY A., Colak S., Yagiz B., COŞKUN B. N., Omma A., YILDIZ Y., et al.

JOURNAL OF VASCULAR SURGERY-VENOUS AND LYMPHATIC DISORDERS , cilt.9, sa.6, ss.1451-1459, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

108. Can anticarbamylated protein antibodies be used to support the diagnosis of systemic lupus erythematosus?

Özdemir B., Erden A., Erten A., Yeşil T. H., Allşlk M., KÜÇÜKŞAHİN O.

Biomarkers in Medicine , cilt.15, sa.14, ss.1253-1260, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

109. Prevalence of sarcopenia and clinical implications in patients with newly diagnosed rheumatoid arthritis

Ekici R., Erden A., Güven S. C., Armağan B., Özdemir B., Karakaş Ö., et al.

Nutrition , cilt.90, 2021 (SCI-Expanded, Scopus)

110. Comment on: What is the meaning of ANCA positivity in IgG4-related disease?

Apaydin H., Armaǧan B., Güven S. C., Omma A., KÜÇÜKŞAHİN O., Erden A.

Rheumatology (Bulgaria) , cilt.60, sa.9, 2021 (Scopus)

111. A single center experience of intravenous immunoglobulin treatment in Covid-19

Omma A., Erden A., Armağan B., Güven S. C., Karakaş Ö., Şahiner E. S., et al.

International Immunopharmacology , cilt.98, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

112. COVID-19 and eosinophilic granulomatosis with polyangiitis or COVID-19 mimicking eosinophilic granulomatosis with polyangiitis?

Özdemir B., Erden A., Güven S. C., Armagan B., Apaydin H., Karakas Ö., et al.

Rheumatology International , cilt.41, sa.8, ss.1515-1521, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

113. Uveitis-related Factors in Patients With Spondyloarthritis: TReasure Real-Life Results

Yaşar Bilge N. Ş., Kalyoncu U., Atagündüz P., Dalkılıç E., Pehlivan Y., Küçükşahin O., et al.

American Journal of Ophthalmology , cilt.228, ss.58-64, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

114. Biological and targeted-synthetic disease-modifying antirheumatic drugs with concomitant methotrexate or leflunomide in rheumatoid arthritis: Real-life TReasure prospective data

Kimyon G., KALYONCU U., KİRAZ S., Bes C., COŞKUN N. F., YAĞIZ B., et al.

Clinical and Experimental Rheumatology , cilt.39, sa.4, ss.852-858, 2021 (SCI-Expanded, Scopus)

115. Association of disease characteristics with the temporal sequence of skin and musculoskeletal disease onset in psoriatic arthritis

Tascilar K., Bayindir O., Dogru A., Tinazzi I., Kimyon G., Ozisler C., et al.

BRITISH JOURNAL OF DERMATOLOGY , cilt.184, ss.1202-1203, 2021 (SCI-Expanded, Scopus)

116. Disease characteristics of psoriatic arthritis patients may differ according to age at psoriasis onset: cross-sectional data from the Psoriatic Arthritis-International Database

Bilgin E., Aydin S. Z., Tinazzi I., Bayindir O., Kimyon G., Ozisler C., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.39, sa.3, ss.532-536, 2021 (SCI-Expanded, Scopus)

117. Predictive values of biochemical markers as early indicators for severe COVID-19 cases in admission

Gemcioglu E., Davutoglu M., Catalbas R., Karabuga B., Kaptan E., Aypak A., et al.

Future Virology , cilt.16, sa.5, ss.353-367, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

118. QuantiFERON®-TB Gold In-Tube test can be used for screening latent tuberculosis before biological treatment in a Bacille Calmette-Guérin (BCG)-vaccinated country: the HUR-BIO single-center real-life results

Seyhoglu E., UYAROĞLU O. A., Erden A., KILIÇ L., KARADAĞ Ö., AKDOĞAN A., et al.

Clinical Rheumatology , cilt.40, sa.5, ss.2027-2035, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

119. COVID-19 outcomes in patients with familial Mediterranean fever: a retrospective cohort study

Güven S. C., Erden A., Karakaş Ö., Armağan B., Usul E., Omma A., et al.

Rheumatology International , cilt.41, sa.4, ss.715-719, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

120. PsART-ID inception cohort: Clinical characteristics, treatment choices and outcomes of patients with psoriatic arthritis

Ayan G., Aydin S. Z., Kimyon G., Ozisler C., Tinazzi I., Dogru A., et al.

Rheumatology (Bulgaria) , cilt.60, sa.4, ss.1755-1762, 2021 (Scopus)

121. Evaluation of 17 patients with COVID-19 pneumonia treated with anakinra according to HScore, SOFA, MuLBSTA, and Brescia-COVID respiratory severity scale (BCRSS) scoring systems

Erden A., Ozdemir B., Karakas O., Mutlu N. M., İZDEŞ S., Kalem A. K., et al.

Journal of Medical Virology , cilt.93, sa.3, ss.1532-1537, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

122. Association between age at disease onset of anti-neutrophil cytoplasmic antibody-associated vasculitis and clinical presentation and short-term outcomes

Monti S., Klersy C., Montecucco C., Caporali R., Watts R., Achilleos K., et al.

Rheumatology (United Kingdom) , cilt.60, sa.2, ss.617-628, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

123. Imaging modalities used in diagnosis and follow-up of patients with Takayasu’s arteritis

Keleşoğlu Dinçer A. B., KILIÇ L., Erden A., KALYONCU U., HAZIROLAN T., KİRAZ S., et al.

Turkish Journal of Medical Sciences , cilt.51, sa.1, ss.224-230, 2021 (SCI-Expanded, Scopus, TRDizin)

124. Can Anakinra and corticosteroid treatment be an effective option in pregnant women with severe Covid-19?

Karakaş Ö., Erden A., Ünlü S., Erol S. A., Goncu Ayhan Ş., Özdemir B., et al.

Women and Health , cilt.61, sa.9, ss.872-879, 2021 (SSCI, Scopus)

125. Convalescent Plasma Reduces Endogenous Antibody Response in COVID-19: A Retrospective Cross-Sectional Study Konvalesan Plazma COVID-19’da Endojen Antikor Yanıtını Azaltır: Retrospektif Kesitsel Bir Çalışma

Omma A., Erden A., Güven S. C., Ateş İ., KÜÇÜKŞAHİN O.

Turkish Journal of Hematology , cilt.38, sa.4, ss.321-324, 2021 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

126. Which hematological markers have predictive value as early indicators of severe COVID-19 cases in the emergency department?

Şan I., Gemcioğlu E., Davutoğlu M., Çatalbaş R., Karabuğa B., Kaptan E., et al.

Turkish Journal of Medical Sciences , cilt.51, sa.6, ss.2810-2821, 2021 (SCI-Expanded, Scopus, TRDizin)

127. Evaluation of inflammatory rheumatic diseases from an emergency medicine perspective

San I., Erden A., Gemcioglu E., KÜÇÜKŞAHİN O.

International Journal of Rheumatic Diseases , cilt.23, sa.12, ss.1670-1675, 2020 (SCI-Expanded, Scopus)

128. False positivity of rose bengal test in patients with covid-19: Case series, uncontrolled longitudinal study

Gemcioglu E., Erden A., Karabuga B., Davutoglu M., Ates I., KÜÇÜKŞAHİN O., et al.

Sao Paulo Medical Journal , cilt.138, sa.6, ss.561-562, 2020 (SCI-Expanded, Scopus)

129. Pregnancy outcomes in partners of male ankylosing spondylitis patients treated with anti-tumour necrosis factor-α biologics: real-life results from a single-centre cross-sectional study

UYAROĞLU O. A., Seyhoglu E., Erden A., KILIÇ L., KARADAĞ Ö., AKDOĞAN A., et al.

Rheumatology International , cilt.40, sa.9, ss.1501-1507, 2020 (SCI-Expanded, Scopus)

130. Current Smoking is Increased in Axial Psoriatic Arthritis and Radiographic Sacroiliitis

Solmaz D., Kalyoncu U., Tinazzi I., Bakirci S., Bayindir O., Dogru A., et al.

Journal of Rheumatology , cilt.47, sa.9, ss.1354-1358, 2020 (SCI-Expanded, Scopus)

131. Acute Ischemic Stroke in a Lupus Anticoagulant-Positive Woman With COVID-19.

Gemcioglu E., Erden A., Davutoglu M., Karabuga B., Kucuksahin O.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases , cilt.26, sa.6, ss.236-237, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

132. Neonatal Lupus Eritematozusa Bağlı Hematolojik, Hepatik, Nörolojik Ve Akciğer Tutulumunun Gözden Geçirilmesi: Hasta Bazlı Sistematik Litearatür Taraması

ERDEN A., BİLGİN E., ARMAĞAN B., SARI A., CEYLAN S., ŞENER Y. Z., et al.

Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi , cilt.53, sa.2, ss.120-124, 2020 (TRDizin)

133. The evaluation of rheumatoid arthritis patients with knee and hip prosthesis: HURBIO biological registry

ARMAĞAN B., ERDAT E. C., ERDEN A., SARI A., KALYONCU U., KİRAZ S., et al.

Ulusal Romatoloji Dergisi , cilt.12, sa.2, ss.39-44, 2020 (Hakemli Dergi)

134. Are type 1 interferons treatment in Multiple Sclerosis as a potential therapy against COVID-19?

Gemcioglu E., Davutoglu M., Ozdemir E. E., Erden A.

Multiple Sclerosis and Related Disorders , cilt.42, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

135. Psoriasis Symptom Inventory (PSI) as a patient-reported outcome in mild psoriasis: Real life data from a large psoriatic arthritis registry

AYDIN S. Z., KİMYON G., ÖZİŞLER C., TARHAN E. F., kasapoğlu günal e., KÜÇÜK A., et al.

EUROPEAN JOURNAL OF RHEUMATOLOGY , cilt.7, sa.2, ss.64-67, 2020 (ESCI, TRDizin)

136. A case of inappropriate antidiuretic hormone secretion syndrome associated with COVID-19 pneumonia

Gemcioglu E., Karabuga B., Ercan A., Erden A.

Acta Endocrinologica , cilt.16, sa.1, ss.110-111, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

137. Geoepidemiology and clinical characteristics of neonatal lupus erythematosus: A systematic literature review of individual patients’ data

Erden A., Fanouriakis A., Kılıç L., Sari A., Armağan B., Bilgin E., et al.

Turkish Journal of Medical Sciences , cilt.50, sa.2, ss.281-290, 2020 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

138. Impact of Having Family History of Psoriasis or Psoriatic Arthritis on Psoriatic Disease

Solmaz D., Bakirci S., Kimyon G., Gunal E. K., DOĞRU A., Bayindir O., et al.

ARTHRITIS CARE & RESEARCH , cilt.72, sa.1, ss.63-68, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

139. A monogenic disease with a variety of phenotypes: Deficiency of adenosine deaminase 2

ÖZEN S., BATU AKAL E. D., Taşkiran E. Z., ÖZKARA H. A., Ünal Ş., Güleray N., et al.

Journal of Rheumatology , cilt.47, sa.1, ss.117-125, 2020 (SCI-Expanded, Scopus)

140. Anti-interleukin-6 (Tocilizumab) therapy in takayasu’s arteritis: A real life experience

KILIÇ L., KARADAĞ Ö., Erden A., Sari A., Armağan B., Yardimci G. K., et al.

Turkish Journal of Medical Sciences , cilt.50, sa.1, ss.31-36, 2020 (SCI-Expanded, Scopus, TRDizin)

141. The role of micro and macrovascular disease in the etiology of left ventricular systolic dysfunction in systemic sclerosis

SARI A., ŞENER Y. Z., ARMAĞAN B., ERDEN A., KILIÇ L., KARADAĞ Ö., et al.

Ulusal Romatoloji Dergisi , cilt.11, sa.2, ss.105-109, 2019 (Hakemli Dergi)

142. The recommendations of Turkish Society for Rheumatology for pregnancy management in rheumatic diseases and the use of antirheumatic drugs during pregnancy

APRAŞ BİLGEN Ş. Ş., KILIÇ L., ERDEN A., ÖZBALKAN AŞLAR Z., BES C., KARABULUT G., et al.

Ulusal Romatoloji Dergisi , cilt.11, sa.2, ss.91-104, 2019 (Hakemli Dergi)

143. Two cases of glutaric aciduria type II: how to differentiate from inflammatory myopathies?

Koca M., Erden A., Armagan B., Sari A., Yildiz F., Ozdamar S., et al.

Acta Clinica Belgica: International Journal of Clinical and Laboratory Medicine , cilt.74, sa.6, ss.451-455, 2019 (SCI-Expanded, Scopus)

144. Serum neopterin and ischemia modified albumin levels are associated with the disease activity of adult immunoglobulin A vasculitis (Henoch-Schönlein purpura)

Omma A., Colak S., Can Sandikci S., Yucel C., Erden A., Sertoglu E., et al.

International Journal of Rheumatic Diseases , cilt.22, sa.10, ss.1920-1925, 2019 (SCI-Expanded, Scopus)

145. Do ANCA-associated vasculitides and IgG4-related disease really overlap or not?

Erden A., Bolek E. Ç., Yardimci K. G., KILIÇ L., Bilgen S. A., KARADAĞ Ö.

International Journal of Rheumatic Diseases , cilt.22, sa.10, ss.1926-1932, 2019 (SCI-Expanded, Scopus)

146. What are the main barriers to achieve minimal disease activity in psoriatic arthritis in real life?

Bakirci S., Solmaz D., Al Osaimi N., Dalkilic E., Can M., Erden A., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.37, sa.5, ss.808-812, 2019 (SCI-Expanded, Scopus)

147. Increased incidence of spondyloarthropathies in patients with Takayasu arteritis: a systematic clinical survey

Esen S. G., Armagan B., Atas N., UÇAR M., Varan O., Erden A., et al.

JOINT BONE SPINE , cilt.86, sa.4, ss.497-501, 2019 (SCI-Expanded, Scopus)

148. Wide heterogeneity in treatment protocols and inappropiate use of prednisolone for anti-Ro/La associated-congenital heart block: a systematic review of 492 cases

ERDEN A., KILIÇ L., SARI A., ARMAĞAN B., BİLGİN E., CEYLAN S., et al.

Ulusal Romatoloji Dergisi , cilt.11, sa.1, ss.10-15, 2019 (TRDizin)

149. Proposal for a simple algorithm to differentiate adult-onset Still’s disease with other fever of unknown origin causes: a longitudinal prospective study

BİLGİN E., HAYRAN K. M., Erden A., Armağan B., Sarı A., KILIÇ L., et al.

Clinical Rheumatology , cilt.38, sa.6, ss.1699-1706, 2019 (SCI-Expanded, Scopus)

150. Switching between biological DMARDs and associated reasons in rheumatoid arthritis and spondyloarthritis treatments: TReasure study-real life data

KALYONCU U., ERTENLİ A. İ., KÜÇÜKŞAHİN O., DALKILIÇ H. E., ERDEN A., BES C., et al.

Ulusal Romatoloji Dergisi , cilt.11, sa.1, ss.1-9, 2019 (Hakemli Dergi)

151. Successful Treatment of Amyloid A-Type Amyloidosis Due to Behcet Disease With Tocilizumab

Ilbay A., Erden A., Sari A., Armagan B., Aktas B. Y., Bolek E. Ç., et al.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , cilt.25, sa.4, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

152. Deficiency of adenosine deaminase 2; special focus on central nervous system imaging

Bulut E., Erden A., KARADAĞ Ö., Oguz K. K., ÖZEN S.

Journal of Neuroradiology , cilt.46, sa.3, ss.193-198, 2019 (SCI-Expanded, Scopus)

153. Change in PsAID-12 scores in patients continuing or discontinuing anti-TNF treatments in psoriatic arthritis: results from the HUR-BIO biologic registry

KALYONCU U., KİRAZ S., Bilgen S. A., KARADAĞ Ö., AKDOĞAN A., KILIÇ L., et al.

Clinical Rheumatology , cilt.38, sa.4, ss.1187-1192, 2019 (SCI-Expanded, Scopus)

154. Correction to: Proposal for a simple algorithm to differentiate adult-onset Still's disease with other fever of unknown origin causes: a longitudinal prospective study.

Bilgin E., Hayran M., Erden A., Armağan B., Sarı A., Kılıç L., et al.

Clinical rheumatology , cilt.38, sa.4, ss.1193-1194, 2019 (SCI-Expanded, Scopus)

155. Polyarteritis nodosa: lessons from 25 years of experience

Sönmez H. E., Armağan B., Ayan G., BARUT K., BATU AKAL E. D., Erden A., et al.

Clinical and experimental rheumatology , cilt.37, sa.2, ss.52-56, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

156. Frequency of Behçet’s disease among a group of visually impaired adults

UYAROĞLU O. A., Seyhoglu E., Erden A., Vahabov C., Babaoglu H., Armagan B., et al.

Irish Journal of Medical Science , cilt.188, sa.1, ss.333-336, 2019 (SCI-Expanded, Scopus)

157. Abnormal retinal microvasculature found in active rheumatoid arthritis: A different perspective of microvascular health

Babaoğlu H., Baytaroğlu A., Torğutalp M., Erden A., KADAYIFÇILAR S., KALYONCU U.

Turkish Journal of Medical Sciences , cilt.49, sa.1, ss.20-26, 2019 (SCI-Expanded, Scopus, TRDizin)

158. Capillaroscopic findings in turkish takayasu arteritis patients

AKDOĞAN A., Erden A., Firat Şentürk E., KILIÇ L., Sari A., Armağan B., et al.

Turkish Journal of Medical Sciences , cilt.49, sa.5, ss.1303-1307, 2019 (SCI-Expanded, Scopus, TRDizin)

159. Behçet’s disease; A rare refractory patient with vena cava superior syndrome treated with infliximab: a case report and review of the literature

Uyaroglu O. A., Erden A., KILIÇ L., PEYNİRCİOĞLU B., KARADAĞ Ö., KALYONCU U.

Acta Clinica Belgica: International Journal of Clinical and Laboratory Medicine , cilt.74, sa.5, ss.364-369, 2019 (SCI-Expanded, Scopus)

160. Low disease activity—irrespective of serologic status at baseline—associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study

Fanouriakis A., Adamichou C., Koutsoviti S., Panopoulos S., Staveri C., Klagou A., et al.

Seminars in Arthritis and Rheumatism , cilt.48, sa.3, ss.467-474, 2018 (SCI-Expanded, Scopus)

161. Rituximab therapy in renal amyloidosis secondary to rheumatoid arthritis

KILIÇ L., Erden A., Sener Y. Z., Armagan B., Sari A., KALYONCU U., et al.

Biomolecules , cilt.8, sa.4, 2018 (SCI-Expanded, Scopus)

162. Axial psoriatic arthritis: the impact of underdiagnosed disease on outcomes in real life

Aydin S. Z., KÜÇÜKŞAHİN O., KILIÇ L., DOĞRU A., Bayindir O., Ozisler C., et al.

Clinical Rheumatology , cilt.37, sa.12, ss.3443-3448, 2018 (SCI-Expanded, Scopus)

163. Comparing immunoglobulin A vasculitis (Henoch–Schönlein purpura) in children and adults: a single-centre study from Turkey

BATU AKAL E. D., Sarı A., Erden A., SÖNMEZ H., Armağan B., KALYONCU U., et al.

Scandinavian Journal of Rheumatology , cilt.47, sa.6, ss.481-486, 2018 (SCI-Expanded, Scopus)

164. Is the PET/CT first choice for differential diagnosis of fever of FUO/IUO?

Armagan B., Erden A., Beydas O., Sari A., KILIÇ L., KALYONCU U.

Annals of the Rheumatic Diseases , cilt.77, sa.11, 2018 (SCI-Expanded, Scopus)

165. Which definition should be used to determine colchicine resistance among patients with familial Mediterranean fever?

Erden A., BATU AKAL E. D., Sarı A., Sönmez H. E., Armagan B., Demir S., et al.

Clinical and experimental rheumatology , cilt.36, sa.6, ss.97-102, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

166. A retrospective study comparing the phenotype and outcomes of patients with polyarteritis nodosa between UK and Turkish cohorts

KARADAĞ Ö., Erden A., BİLGİNER Y., Gopaluni S., Sari A., Armagan B., et al.

Rheumatology International , cilt.38, sa.10, ss.1833-1840, 2018 (SCI-Expanded, Scopus)

167. In early arthritis patients, high HAQ at baseline and DAS28 at three months predict suboptimal outcomes at two years: A retrospective cohort study

Fanouriakis A., Papalopoulos I., Gergianaki I., Spyrou G., Erden A., Rapsomaniki P., et al.

Clinical and Experimental Rheumatology , cilt.36, sa.5, ss.806-813, 2018 (SCI-Expanded, Scopus)

168. Evaluation of Vitamin B12 Deficiency and Associated Factors in Patients with Systemic Sclerosis

Tas Kilic D., AKDOĞAN A., KILIÇ L., Sari A., Erden A., Armagan B., et al.

Journal of Clinical Rheumatology , cilt.24, sa.5, ss.250-254, 2018 (SCI-Expanded, Scopus)

169. A rare cause of proximal muscle weakness: immune necrotising myopathy

Can Guven D., Erden A., KILIÇ L., Ozdamar S. E., KARADAĞ Ö.

Scottish Medical Journal , cilt.63, sa.3, ss.82-86, 2018 (SCI-Expanded, Scopus)

170. Pulmonary hypertension in Takayasu arteritis

Sari A., Sener Y. Z., Firat E., Armagan B., Erden A., Oksul M., et al.

International Journal of Rheumatic Diseases , cilt.21, sa.8, ss.1634-1639, 2018 (SCI-Expanded, Scopus)

171. Familial Mediterranean Fever: New Insights Into Cancer Immunoprevention? Comment on the Article by Brenner et al

BİLGİN E., Erden A., DİZDAR Ö.

Arthritis and Rheumatology , cilt.70, sa.7, ss.1167, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

172. Nationwide Experience With Off-Label Use of Interleukin-1 Targeting Treatment in Familial Mediterranean Fever Patients

AKAR S., Cetin P., KALYONCU U., KARADAĞ Ö., Sari I., Cinar M., et al.

ARTHRITIS CARE & RESEARCH , cilt.70, sa.7, ss.1090-1094, 2018 (SCI-Expanded, Scopus)

173. Assessment of subclinical atherosclerosis in psoriatic arthritis patients without clinically overt cardiovascular disease or traditional atherosclerosis risk factors

APRAŞ BİLGEN Ş. Ş., KALYONCU U., ERDEN A., CANPOLAT U., KILIÇ L., KARADAĞ Ö., et al.

TURK KARDIYOLOJI DERNEGI ARSIVI , cilt.46, sa.5, ss.358-365, 2018 (Scopus, TRDizin) Sürdürülebilir Kalkınma

174. Remission of relapsing polychondritis after successful treatment of myelodysplastic syndrome with azacitidine: a case and review of the literature

ERDEN A., BİLGİN E., KILIÇ L., SARI A., ARMAĞAN B., BÜYÜKAŞIK Y., et al.

DRUG METABOLISM AND PERSONALIZED THERAPY , cilt.33, sa.2, ss.105-108, 2018 (Scopus)

175. Some concerns and improvements from Turkey

ÇINAR O. E., Erden A., Sari A., Armagan B., KILIÇ L.

Annals of the Rheumatic Diseases , cilt.77, sa.6, 2018 (SCI-Expanded, Scopus)

176. Blood group 'A' may have a possible modifier effect on familial Mediterranean fever and blood group '0' may be associated with colchicine resistance

Erden A., BATU AKAL E. D., Armagan B., Sönmez H. E., Sari A., Demir S., et al.

Biomarkers in Medicine , cilt.12, sa.6, ss.565-572, 2018 (SCI-Expanded, Scopus)

177. Aspergillus Pneumonia in a Patient With Adult-Onset Still Disease Successfully Treated With Anakinra

BİLGİN E., Erden A., KILIÇ L., Sari A., Armagan B., KALYONCU U., et al.

Journal of Clinical Rheumatology , cilt.24, sa.3, ss.156-158, 2018 (SCI-Expanded, Scopus)

178. Pulmonary aspergillosis after treatment with infliximab in Still’s disease and a literature review of Still’s disease and pulmonary aspergillosis

ŞEYHOĞLU E., ERDEN A., KILIÇ L., KARADAĞ Ö., ARIKAN AKDAĞLI S., AKDOĞAN A., et al.

EUROPEAN JOURNAL OF RHEUMATOLOGY , cilt.5, sa.1, ss.75-78, 2018 (TRDizin)

179. Starting of biological disease modifying antirheumatic drugs may be postponed in rheumatoid arthritis patients with multimorbidity

Armagan B., Sari A., Erden A., KILIÇ L., Erdat E. C., Kilickap S., et al.

Medicine (United States) , cilt.97, sa.13, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

180. Clinical and laboratory features of metformin intoxication in suicidal patients attending an intensive care unit

Cetinkaya A., Avci D., Erden A., Akca O., Ozer O., Kalan U., et al.

Nigerian Journal of Clinical Practice , cilt.21, sa.2, ss.143-148, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

181. Increased psoriasis frequency in patients with familial Mediterranean fever

Erden A., BATU AKAL E. D., Seyhoğlu E., Sari A., Sönmez H. E., Armagan B., et al.

Upsala Journal of Medical Sciences , cilt.123, sa.1, ss.57-61, 2018 (SCI-Expanded, Scopus)

182. IgG4-related sclerosing disease with mesenteric and retroperitoneal involvement

Yetkin D. I., ONUR M. R., KARADAĞ Ö., ERDEN A., AKPINAR E., KÖSEMEHMETOĞLU K.

EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE , cilt.48, sa.4, ss.767-769, 2017 (Scopus)

183. Retention Rate of Etanercept in Patients with Rheumatoid Arthritis Is Better Than That of Monoclonal Antibody

ERDEN A., KILIÇ L., KARADAĞ Ö., KİRAZ S., KILIÇKAP S., AKDOĞAN A., et al.

Acta Medica , cilt.48, sa.3, ss.11-17, 2017 (Hakemli Dergi)

184. Rituximab experience in patients with long-standing systemic sclerosis-associated interstitial lung disease: A series of 14 patients

Sari A., Guven D., Armagan B., Erden A., KALYONCU U., KARADAĞ Ö., et al.

Journal of Clinical Rheumatology , cilt.23, sa.8, ss.411-415, 2017 (SCI-Expanded, Scopus)

185. An Independent Risk Factor for Diabetic Retinopathy: Uric Acid

avcı d., KARAHAN S., çetinkaya a., karagöz h., esmeray k., buğday i., et al.

Journal of Global Diabetes Clinical Metabolism , cilt.2, sa.4-022, ss.1-5, 2017 (Hakemli Dergi) Sürdürülebilir Kalkınma

186. Rare occupational cause of nasal septum perforation: Nickel exposure

Bolek E. Ç., Erden A., Kulekci C., KALYONCU U., KARADAĞ Ö.

International journal of occupational medicine and environmental health , cilt.30, sa.6, ss.963-967, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

187. Evaluation of psoriasis patients with a rheumatologic questionnaire efficiently aids in early detection of psoriatic arthritis

DOĞAN GÜNAYDIN S., ATAKAN Z. N., KOÇ YILDIRIM S., KALYONCU U., ERDEN A.

DERI HASTALIKLARI VE FRENGI ARSIVI , cilt.51, sa.3, ss.88-91, 2017 (TRDizin) Sürdürülebilir Kalkınma

188. Revision of the demographic and clinical data of patients with ulcerative colitis in Turkey

karagöz h., ERDEN A., karaman h., KARAMAN A.

Medicinski Glasnik , cilt.14, sa.2, ss.224-228, 2017 (Scopus)

189. Romatizmalı hastalar için bir yaşam kalitesi ölçeğinin geliştirilmesi: madde havuzunun oluşturulması

ÜNAL E., ARIN G., KARACA N. B., KİRAZ S., AKDOĞAN A., KALYONCU U., et al.

Journal of Exercise Therapy and Rehabilitation , cilt.4, sa.2, ss.67-75, 2017 (TRDizin)

190. Comparing polyarteritis nodosa in children and adults: a single center study

Erden A., BATU AKAL E. D., SÖNMEZ H., Sarı A., Armagan B., Arıcı Z. S., et al.

International Journal of Rheumatic Diseases , cilt.20, sa.8, ss.1016-1022, 2017 (SCI-Expanded, Scopus)

191. The values of mean platelet volume and the mean platelet volume/platelet ratio for predicting deep venous thrombosis in Behçet's disease

Erden F., Karagoz H., Avci A., Avci D., Cetinkaya A., Erden A.

LaboratoriumsMedizin , cilt.41, sa.3, ss.153-157, 2017 (SCI-Expanded, Scopus)

192. The Psoriatic Arthritis Registry of Turkey: Results of a multicentre registry on 1081 patients

KALYONCU U., Bayindir Ö., Öksüz M. F., DOĞRU A., Kimyon G., Tarhan E. F., et al.

Rheumatology (United Kingdom) , cilt.56, sa.2, ss.279-286, 2017 (SCI-Expanded, Scopus)

193. Assessment of the HScore for reactive haemophagocytic syndrome in patients with rheumatic diseases

BATU AKAL E. D., Erden A., Seyhoğlu E., KILIÇ L., BÜYÜKAŞIK Y., KARADAĞ Ö., et al.

Scandinavian Journal of Rheumatology , cilt.46, sa.1, ss.44-48, 2017 (SCI-Expanded, Scopus)

194. Which one is best? Platelet/lymphocyte ratio, neutrophil/lymphocyte ratio or both in determining deep venous thrombosis in behcet’s disease?

Erden F., Karagoz H., Avci A., Avci D., Cetinkaya A., BAHADIR Ş., et al.

Biomedical Research (India) , cilt.28, sa.12, ss.5304-5309, 2017 (Scopus)

195. The clinical features and outcomes of Turkish patients with IgG4-related disease: A single-center experience

KARADAĞ Ö., Erden A., AYHAN E. A., Bölek E. Ç., KALYONCU U., Armağan B., et al.

Turkish Journal of Medical Sciences , cilt.47, sa.5, ss.1307-1314, 2017 (SCI-Expanded, Scopus, TRDizin)

196. The role of blood groups in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis

Karagoz H., Erden A., Ozer O., Cetinkaya A., Avci D., Gencer V., et al.

Acta Medica Mediterranea , cilt.33, sa.2, ss.205-210, 2017 (SCI-Expanded, Scopus)

197. Orbital Involvement and Ocular Surface Changes in IgG4-Related Systemic Disease

KOCABEYOĞLU S., KARADAĞ Ö., Mocan M. C., Erden A., Irkec M.

Cornea , cilt.35, sa.11, ss.1449-1453, 2016 (SCI-Expanded, Scopus)

198. The reporting of patient-reported outcomes in studies of patients with rheumatoid arthritis: A systematic review of 250 articles

KILIÇ L., Erden A., Bingham C. O., Gossec L., KALYONCU U.

Journal of Rheumatology , cilt.43, sa.7, ss.1300-1305, 2016 (SCI-Expanded, Scopus)

199. Are the blood groups of women with preeclampsia a risk factor for the development of hypertension postpartum?

Avci D., Karagoz H., Ozer O., Esmeray K., Bulut K., Aykas F., et al.

Therapeutics and Clinical Risk Management , cilt.12, ss.617-622, 2016 (SCI-Expanded, Scopus)

200. Effect of anterior uveitis in Behçet’xxs disease onneutrophil to lymphocyte ratio

avcı a., avcı d., ÇINAR S. L., çetinkaya a., Karahan S., ERDEN A., et al.

INTERNATIONAL EYE SCIENCE , cilt.16, sa.4, ss.607-609, 2016 (Scopus)

201. Acute Pancreatitis Caused By Mushroom Poisoning: A Report of Two Cases

karahan s., ERDEN A., çetinkaya a., avcı d., ortaköylüoğlu a. i., karagoz h., et al.

Journal of Investigative Medicine High Impact Case Reports , cilt.4, sa.1, ss.1-3, 2016 (Scopus)

202. The role of blood groups in the development of diabetes mellitus after gestational diabetes mellitus

Karagoz H., Erden A., Ozer O., Esmeray K., Cetinkaya A., Avci D., et al.

Therapeutics and Clinical Risk Management , cilt.11, ss.1613-1617, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

203. Golimumab using in ankylosing spondylitis patients: HUR-BIO/Spondyloarthritis real life experience

ERDEN A., KILIÇ L., KARADAĞ Ö., AKDOĞAN A., APRAŞ BİLGEN Ş. Ş., KİRAZ S., et al.

RAED Dergisi , cilt.7, sa.1, ss.6-9, 2015 (Hakemli Dergi)

204. Persistence of cardiovascular risk factors in women with previous preeclampsia: A long-term follow-up study

Aykas F., Solak Y., Erden A., Bulut K., Dogan S., Sarli B., et al.

Journal of Investigative Medicine , cilt.63, sa.4, ss.641-645, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

205. Reversible slurred speech related to capecitabine and lapatinib combination in patients with breast cancer

Mutlu H., Büyükçelik A., Akça Z., Erden A.

Journal of Oncology Pharmacy Practice , cilt.21, sa.1, ss.72-73, 2015 (Scopus) Sürdürülebilir Kalkınma

206. Non alcoholic steatohepatitis is associated with subclinical impairment in left ventricular function measured by speckle tracking echocardiography

Baktır A. O., Şarlı B., Altekin R. E., Karaman A., Arınç H., Sağlam H., et al.

ANADOLU KARDIYOLOJI DERGISI , cilt.15, sa.2, ss.137-142, 2015 (SCI-Expanded)

207. Spondiloartritlere Özel Hastalıklar:Psöriyazis, İnflamatuar Barsak Hastalığı, Üveit

ERDEN A., ERTENLİ A. İ.

Turkiye Klinikleri J Rheumatol , cilt.8, sa.1, ss.44-50, 2015 (Hakemli Dergi)

208. Clinicopathologic case discussion: systemic onset juvenil idiopathic arthritis and acut-subacute heart failure

KILIÇ L., TORĞUTALP M., ERDEN A., KALYONCU U.

RAED Dergisi , cilt.6, sa.2, ss.67-72, 2014 (Hakemli Dergi)

209. Is hypertriglyceridemia a prognostic factor in sepsis?

Cetinkaya A., Erden A., Avci D., Karagoz H., Karahan S., Basak M., et al.

Therapeutics and Clinical Risk Management , cilt.10, sa.1, ss.147-150, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

210. Disseminated intravascular coagulopathy caused by Kikuchi-Fujimoto disease resulting in death: first case report in Turkey

USLU YURTERİ E., gürbüz s., ERDEN A., AYKAŞ F., karagöz h., Karahan S., et al.

INTERNATIONAL MEDICAL CASE REPORTS JOURNAL , cilt.7, sa.NULL, ss.19-22, 2014 (Scopus)

211. Survival analysis of biliary tract cancer cases in Turkey

Akca Z., Mutlu H., Erden A., Buyukcelik A., Cihan Y. B., Goksu S. S., et al.

Asian Pacific Journal of Cancer Prevention , cilt.15, sa.15, ss.6025-6027, 2014 (SCI-Expanded, Scopus)

212. Lack of sunlight exposure influence on primary glioblastoma survival

Mutlu H., Akca Z., Erden A., Aslan T., Ucar K., Kaplan B., et al.

Asian Pacific Journal of Cancer Prevention , cilt.15, sa.10, ss.4165-4168, 2014 (SCI-Expanded, Scopus)

213. Codeine-induced syndrome of inappropriate antidiuretic hormone: Case report

Karahan S., Karagöz H., Erden A., Avci D., Esmeray K.

Balkan Medical Journal , cilt.31, sa.1, ss.107-109, 2014 (SCI-Expanded, Scopus, TRDizin)

214. Diffüz İdiyopatik İskelet Hiperostozu

ERDEN A., KALYONCU U.

Turkiye Klinikleri J Rheumatol , cilt.7, sa.1, ss.5-10, 2014 (Hakemli Dergi)

215. The Relationship between ABO Blood Group and Glioblastoma Multiforme

AKÇA Z., MUTLU H., ERDEN A., BÜYÜKÇELİK A., SEZER YAMAN E., İNAL A.

Medicine Science , cilt.3, sa.4, ss.1639-1647, 2014 (TRDizin)

216. Uric acid as a potential mediator of cardiovascular morbidity in obstructive sleep apnea syndrome

Kanbay A., Inonu H., Solak Y., Erden A., Uslu E., Yuksel S. A., et al.

European Journal of Internal Medicine , cilt.25, sa.5, ss.471-476, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

217. QT Dispersion Which Predicts Cardiovascular Adverse Event Risk, Increases In Non Alcoholic Fatty Liver Disease

baktır a. o., ŞARLI B., KARAMAN A., ARINÇ H., SAĞLAM H., Karaman H., et al.

Abant Tıp Dergisi , cilt.3, sa.1, ss.33-37, 2014 (TRDizin)

218. Second-line gemcitabine-based chemotherapy regimens improve overall 3-year survival rate in patients with malignant pleural mesothelioma: A multicenter retrospective study

Mutlu H., Gündüz Ş., Karaca H., Büyükçelik A., Cihan Y. B., Erden A., et al.

Medical Oncology , cilt.31, sa.8, 2014 (SCI-Expanded, Scopus)

219. Colchicine intoxication: A report of two suicide cases

Erden A., Karagoz H., Gümüscü H. H., Karahan S., Basak M., Aykas F., et al.

Therapeutics and Clinical Risk Management , cilt.9, sa.1, ss.505-509, 2013 (SCI-Expanded, Scopus)

220. A case of bismuth intoxication with irreversible renal damage

ERDEN A., Karahan S., BULUT K., BAŞAK M., ASLAN T., çetinkaya a., et al.

INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE , cilt.6, sa.NULL, ss.241-243, 2013 (Scopus)

221. Acute liver failure caused by mushroom poisoning: a case report and review of the literature

ERDEN A., Esmeray K., karagöz h., Karahan S., GÜMÜŞÇÜ H. H., BAŞAK M., et al.

INTERNATIONAL MEDICAL CASE REPORTS JOURNAL , cilt.6, sa.NULL, ss.85-90, 2013 (Scopus)

222. Serum gamma glutamyl transferase and alanine transaminase concentrations predict endothelial dysfunction in patients with non-alcoholic steatohepatitis

Arinc H., Sarli B., Baktir A. O., Saglam H., Demirci E., Dogan Y., et al.

Upsala Journal of Medical Sciences , cilt.118, sa.4, ss.228-234, 2013 (SCI-Expanded, Scopus)

223. GERIATRIC VERSUS NON GERIATRIC GROUPS IN POSTMENOPAUSAL BREAST CANCER PATIENTS LYMPHOVASCULAR INVASION IS SIGNIFICANTLY DIFFERENT

MUTLU H., akça z., ERDEN A., aslan t., benderli cihan y., büyükçelik a.

TURK GERIATRI DERGISI , cilt.16, sa.3, ss.305-308, 2013 (SCI-Expanded, SSCI, Scopus, TRDizin) Sürdürülebilir Kalkınma

224. Suicide commitment with metformin: Our experience with five cases

Avci D., Çetinkaya A., Karahan S., Oǧuzhan N., Karagöz H., Başak M., et al.

Renal Failure , cilt.35, sa.6, ss.863-865, 2013 (SCI-Expanded, Scopus)

225. Lithium intoxication and nephrogenic diabetes insipidus: a case report and review of literature

ERDEN A., karagöz h., BAŞAK M., Karahan S., çetinkaya a., avcı d., et al.

INTERNATIONAL JOURNAL OF GENERAL MEDICINE , cilt.6, sa.NULL, ss.535-539, 2013 (Scopus)

226. Adjuvan Kemoradyoterapi Alan Meme Kanserli Hastalarda Tümör Lokalizasyonunun Akciğer Toksisitesine Etkisi

MUTLU H., AKÇA Z., BERK V., ERDEN A., ASLAN T., UĞUR H.

KONURALP TIP DERGISI , cilt.5, sa.2, ss.33-35, 2013 (Hakemli Dergi)

227. Alteration in mean platelet volume and platicrit values in patients with cancer that developed thrombosis

Mutlu H., Artiş T. A., Erden A., Akca Z.

Clinical and Applied Thrombosis/Hemostasis , cilt.19, sa.3, ss.331-333, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

228. The Relationship Among Mean Platelet Volume,Platelet Count, Risk Factors and ThromboembolicEvent in Patients with Cancer

MUTLU H., AKÇA Z., BENDERLİ CİHAN Y., ERDEN A., ASLAN T., UĞUR H., et al.

Yeni Tıp Dergisi , cilt.30, sa.2, ss.89-92, 2013 (TRDizin)

229. Gastrointestinal kanama ile başvuran erişkin başlangıçlı Henoch-Schönlein vasküliti ve ankilozan spondilitli bir olgu

BAŞAK M., ERDEN A., BULUT K., AYKAŞ F., karaman h., KARAMAN A.

Endoskopi , cilt.21, sa.1, ss.19-21, 2013 (TRDizin)

230. Blue lunula related with hydroxyurea Hidroksiüre i̇lişkili mavi lunula

ÜSKÜDAR TEKE H., Erden A.

Turkish Journal of Hematology , cilt.30, sa.1, ss.100-101, 2013 (SCI-Expanded, Scopus, TRDizin)

231. Malignant peritoneal mesothelioma: Two cases andliterature review

OĞUZ A., KARAMAN A., AYKAŞ F., ERDEN A.

International Journal of Medicineand Medical Sciences , cilt.5, sa.3, ss.95-96, 2013 (Hakemli Dergi)

232. Alteration of Complementary and Alternative Medicine Usage in Patients With Cancer in Turkey

MUTLU H., AKÇA Z., BENDERLİ CİHAN Y., ASLAN T., ERDEN A., BÜYÜKÇELİK A.

Medicine Science , cilt.2, sa.3, ss.757-763, 2013 (Hakemli Dergi)

233. Secondline chemotherapy versus best supportive care in patient with malignant pleural mesothelioma: A retrospective study

Mutlu H., Buyukcelik A., Karaca H., Aksahin A., Berk V., Aslan T., et al.

Asian Pacific Journal of Cancer Prevention , cilt.14, sa.6, ss.3887-3889, 2013 (SCI-Expanded, Scopus)

234. The Optimal Chemotherapy Timing in Patients with Inoperable Locally Advanced Non Small Cell Lung Cancer

MUTLU H., BÜYÜKÇELİK A., ASLAN T., ERDEN A., AKÇA Z.

MEDICINSKI ARHIV , cilt.67, sa.2, ss.104-106, 2013 (Scopus) Sürdürülebilir Kalkınma

235. Is sunlight a predisposing factor for triple negative breast cancer in Turkey?

Mutlu H., Büyükçelik A., Çolak T., Özdoǧan M., Erden A., Aslan T., et al.

Asian Pacific Journal of Cancer Prevention , cilt.14, sa.2, ss.801-803, 2013 (SCI-Expanded, Scopus)

236. Relationship between colonic polyp type and the neutrophil/lymphocyte ratio as a biomarker

Karaman H., Karaman A., Erden A., Poyrazoglu O. K., KARAKÜKCÜ Ç., Tasdemir A.

Asian Pacific Journal of Cancer Prevention , cilt.14, sa.5, ss.3159-3161, 2013 (SCI-Expanded, Scopus)

237. Does sunlight exposure improve survival in patients with non-small cell lung cancer?

Mutlu H., Buyukcelik A., Aksahin A., Kibar M., Cihan Y. B., Kaya E., et al.

Asian Pacific Journal of Cancer Prevention , cilt.14, sa.11, ss.6301-6304, 2013 (SCI-Expanded, Scopus)

238. Should FISH Test be Performed to all Patients With Breast Cancer?

MUTLU H., KARACA H., AKÇA Z., ALTUNER TORUN Y., ERDEN A., ASLAN T., et al.

Medicine Science , cilt.2, sa.2, ss.539-547, 2013 (Hakemli Dergi)

239. Is season a prognostic factor in breast cancer?

Mutlu H., Akca Z., Cihan Y. B., Kurnaz F., Aslan T., Erden A., et al.

Asian Pacific Journal of Cancer Prevention , cilt.14, sa.2, ss.743-746, 2013 (SCI-Expanded, Scopus)

240. An Acute Edematous Pancreatitis Case Developed On The Basis Of Hypertriglyceridemia

ASLAN T., ERDEN A., karagöz h., Karahan S., AYKAŞ F., USLU YURTERİ E., et al.

MEDICINSKI ARHIV , cilt.67, sa.4, ss.295-296, 2013 (Scopus)

241. Staging with PET-CT in patients with locally advanced non small cell lung cancer is superior to conventional staging methods in terms of survival

Mutlu H., Buyukcelik A., Erden A., Aslan T., Akca Z., Kaya E., et al.

Asian Pacific Journal of Cancer Prevention , cilt.14, sa.6, ss.3743-3746, 2013 (SCI-Expanded, Scopus)

242. OSTEOPOROSIS ASSOCIATED WITH AROMATASE INHIBITORS ISDIFFERENT FROM POST-MENOPAUSAL OSTEOPOROSIS

MUTLU H., ASLAN T., yılmaz silov g., ERDEN A., BENDERLİ CİHAN Y., AKÇA Z., et al.

ADVANCE LABORATORY MEDICINE INTERNATIONAL , cilt.3, sa.1, ss.1-5, 2012 (Hakemli Dergi)

243. THE NEUTROPHIL/LYMPHOCYTE RATIO MAY BE AN INDICATOR OF ADVANCED DISEASE IN PATIENTS WITH NON SMALL CELL LUNG CANCER

MUTLU H., ERDEN A., ASLAN T., AKÇA Z., OĞUZ A., BÜYÜKÇELİK A.

ADVANCE LABORATORY MEDICINE INTERNATIONAL , cilt.2, sa.4, ss.142-148, 2012 (Hakemli Dergi)

244. Single-dose-dexketoprofen-induced acute kidney injury due to massive rhabdomyolysis

Sav T., Unal A., Erden A., Gunal A. I.

International Urology and Nephrology , cilt.44, sa.5, ss.1581-1583, 2012 (SCI-Expanded, Scopus)

245. Treatment regimen with bevacizumab decreases mean platelet volume in patients with metastatic colon cancer

Mutlu H., Berk V., Karaca H., Erden A., Aslan T., Akca Z.

Clinical and Applied Thrombosis/Hemostasis , cilt.18, sa.5, ss.546-548, 2012 (SCI-Expanded, Scopus)

246. Periton Tüberkülozu Olgusu

KARAMAN A., ERDEN A., Karaman H., USLU YURTERİ E., ÖZGÜL GÜMÜŞ Ü.

Ankara Medical Journal , cilt.12, sa.2, ss.103-105, 2012 (TRDizin)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 145

1. [PS-228] Sistemik lupus eritematozus hastalarında ciddi immün trombositopeni tedavisinin uzun dönem sonuçları; Lupus çalışma grubu verisi

KİMYON G., TEMİZ KARADAĞ D., GÖKÇEN N., ÇEFLE A., AVCU A., ALİBAZ F., et al.

25. ULUSAL ROMATOLOJİ KONGRESİ, Antalya, Türkiye, 12 - 16 Kasım 2025, cilt.17, ss.338-339, (Özet Bildiri)

2. ABS0480 DISTINGUISHING CLINICAL FEATURES BETWEEN LIMITED AND DIFFUSE SUBTYPES IN EARLY-STAGE SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE IS CHALLENGING

TEMİZ KARADAĞ D., OKYAR B., ERSÖZLÜ E. D., Yılmaz A., BEKTAŞ E., BES C., et al.

European Congress of Rheumatology-EULAR 2025, Barselona, İspanya, 11 - 14 Haziran 2025, cilt.84, ss.2289-2290, (Özet Bildiri)

3. ABS1074 BEHÇETS DISEASE BEYOND THE CRITERIA: INSIGHTS FROM A TERTIARY CENTER IN TURKEY

FIRLATAN B., Şahin Mavi E. A., Kart Bayram G. S., Bulat B., EKİCİ M., ÜNALDI E., et al.

European Congress of Rheumatology-EULAR 2025, Barselona, İspanya, 11 - 14 Haziran 2025, cilt.84, ss.1577, (Özet Bildiri)

4. POS1103 ASSESSMENT OF RESPIRATORY PHYSIOLOGY VIA OSCILLOMETRIC METHODS IN THE MONITORING OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH SYSTEMIC SCLEROSIS

VASİ İ., KARDAŞ R. C., DUYGULU S., KAYA B., YILDIRIM D., DURAN R., et al.

European Congress of Rheumatology-EULAR 2025, Barselona, İspanya, 11 - 14 Haziran 2025, cilt.84, ss.1190, (Özet Bildiri)

5. ABS0933 EVALUATION OF MITOCHONDRIAL DYSFUNCTION USING MT-ATP6 LEVELS IN ANCA-ASSOCIATED VASCULITIS AND IgG4-RELATED DISEASE

KARDAŞ R. C., VASİ İ., YILDIRIM D., KAYA B., DURAN R., ÇAKIR İ. Y., et al.

European Congress of Rheumatology-EULAR 2025, Barselona, İspanya, 11 - 14 Haziran 2025, cilt.84, ss.1532-1533, (Özet Bildiri)

6. ABS0507 CORTICOSTEROID USE IN EARLY SYSTEMIC SCLEROSIS: INSIGHTS FROM THE TURKISH SYSTEMIC SCLEROSIS DATABASE

UĞURLU Z., OKYAR B., ERSÖZLÜ E. D., ÖZGÜR D. S., BES C., ÇEFLE A., et al.

European Congress of Rheumatology-EULAR 2025, Barselona, İspanya, 11 - 14 Haziran 2025, cilt.84, ss.2290-2292, (Özet Bildiri)

7. ABS0568 PREVALENCE AND RISK FACTORS FOR CARDIOVASCULAR INVOLVEMENT IN PATIENTS WITH EARLY SYSTEMIC SCLEROSIS

amikishiyev s., OKYAR B., ERSÖZLÜ E. D., ÖZGÜR D. S., BES C., ÇEFLE A., et al.

European Congress of Rheumatology-EULAR 2025, Barselona, İspanya, 11 - 14 Haziran 2025, cilt.84, ss.2296-2297, (Özet Bildiri)

8. ABS0539 TREATMENT PREFERENCES IN EARLY SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: REAL-WORLD DATA FROM THE TURKISH SYSTEMIC SCLEROSIS REGISTRY

BİLİCİ R., OKYAR B., ERSÖZLÜ E. D., ÖZGÜR D. S., BES C., ÇEFLE A., et al.

European Congress of Rheumatology-EULAR 2025, Barselona, İspanya, 11 Haziran 2025, cilt.84, ss.2293-2294, (Özet Bildiri)

9. ABS0495 THE RHEUMATIC DISEASE COMORBIDITY INDEX (RDCI) AS A PREDICTOR OF DISEASE SEVERITY AND RENAL INVOLVEMENT IN ANCA-ASSOCIATED VASCULITIS

GÖKHAN N. S., KARDAŞ R. C., KARADUMAN İ., VASİ İ., YILDIRIM D., KAYA B., et al.

European Congress of Rheumatology-EULAR 2025, Barselona, İspanya, 11 - 14 Haziran 2025, cilt.84, ss.2367-2368, (Özet Bildiri)

10. POS1084 Neutrophil Elastase as a Marker of NETosis in IgG4-Related Disease and Sjögrens Syndrome

Çimen Y., KARDAŞ R. C., YILDIRIM D., VASİ İ., KAYA B., DURAN R., et al.

European Congress of Rheumatology-EULAR 2025, Barselona, İspanya, 11 - 14 Haziran 2025, cilt.84, ss.1177, (Özet Bildiri)

11. POS1090 Clinical Predictors of Treatment Discontinuation in Adult-Onset Stills Disease

ÇAKIR İ. Y., MAHMUTOĞLU Y., KARDAŞ R. C., USLU E., SEZER S., YAYLA M. E., et al.

European Congress of Rheumatology-EULAR 2025, Barselona, İspanya, 11 - 14 Haziran 2025, cilt.84, ss.1181, (Özet Bildiri)

12. ABS0447 DOES OVERLAP SYNDROME CONTRIBUTE TO CLINICAL DIFFERENCES IN SYSTEMIC SCLEROSIS SKIN SUBTYPES

VASİ İ., OKYAR B., ERSÖZLÜ E. D., ÖZGÜR D. S., BES C., ÇEFLE A., et al.

European Congress of Rheumatology-EULAR 2025, Barselona, İspanya, 11 - 14 Haziran 2025, cilt.84, ss.2286-2287, (Özet Bildiri)

13. ABS0748 PREVALENCE, SCREENING RATES, AND RISK FACTORS OF OSTEOPOROSIS IN SYSTEMIC SCLEROSIS PATIENTS

VASİ İ., Mammadova A., KÜÇÜK H., ERDEN A.

European Congress of Rheumatology-EULAR 2025, Barselona, İspanya, 11 - 14 Haziran 2025, cilt.84, ss.2310-2311, (Özet Bildiri)

14. POS1213 WHAT HAS THE FDAS BLACK BOX WARNINGS FOR JAKi CHANGED IN REAL LIFE HÜR-BIO REAL-LIFE EXPERIENCE

Bulat B., EKİCİ M., FIRLATAN B., Kart Bayram G. S., ÜNALDI E., AYAN G., et al.

European Congress of Rheumatology-EULAR 2025, Barselona, İspanya, 11 Haziran 2025, cilt.84, ss.1276, (Özet Bildiri)

15. POS0583 IL-40: A NOVEL PROINFLAMMATORY B CELL-ASSOCIATED CYTOKINE AND ITS ROLE IN SYSTEMIC SCLEROSIS

Vasi İ., Bağrıaçık E. Ü., Kardaş R. C., Örüklü Demir N., Yaman M., Karakuş R., et al.

European Congress of Rheumatology-EULAR 2025, Barcelona, İspanya, 11 - 14 Haziran 2025, cilt.84, ss.783-784, (Özet Bildiri)

16. ABS0567 TRACING THE PATH TO DIAGNOSIS: INITIAL SYMPTOMS AND DELAYS IN SYSTEMIC SCLEROSIS FROM THE TURKISH NATIONAL REGISTRY

AVANOĞLU GÜLER A., BALTACI M. A., FIRLATAN B., OKYAR B., AVCU A., UĞURLU Z., et al.

European Congress of Rheumatology-EULAR 2025, Barselona, İspanya, 11 - 14 Haziran 2025, cilt.84, ss.2295-2296, (Özet Bildiri)

17. ABS0575 EXPLORING THE ASSOCIATION BETWEEN AUTOANTIBODY PROFILES AND THE DEVELOPMENT OF DIGITAL ULCERS IN SYSTEMIC SCLEROSIS PATIENTS: A COMPREHENSIVE ANALYSIS

YAMANCAN G., KARATAŞ A., ERDEN A., SARI A., babayiğit a., AVANOĞLU GÜLER A., et al.

European Congress of Rheumatology-EULAR 2025, Barselona, İspanya, 11 - 14 Haziran 2025, cilt.84, ss.2299-2300, (Özet Bildiri)

18. Erken sistemik skleroz hastalarında otolog kök hücre nakli için uygun adayların değerlendirilmesi

GÜVEN S. C., AMIKISHIYEV S., ASLAN B., AVANOĞLU GÜLER A., AVCU A., Babayiğit A., et al.

24.Ulusal Romatoloji Kongresi, Muğla, Türkiye, 26 - 30 Ekim 2024, (Özet Bildiri)

19. Erişkin başlangıçlı still hastalığında ilaçsız izlemi öngördüren tanı anındaki faktörler nelerdir?

ÇAKIR İ. Y., MAHMUTOĞLU Y., KARDAŞ R. C., VASİ İ., SEZER S., YAYLA M. E., et al.

24.Ulusal Romatoloji Kongresi, Muğla, Türkiye, 26 - 30 Ekim 2024, (Özet Bildiri)

20. AB1017 SLE PATIENTS EXHIBIT WALL THICKENING IN MAJOR VEINS ACROSS THE BODY

KARADENİZ H., YILDIRIM D., İbrahimhanlı N., koç kanık h. n., VASİ İ., DURAN R., et al.

EULAR 2024 |, Viyana, Avusturya, 12 Haziran 2024, ss.1826-1827, (Tam Metin Bildiri)

21. AB1189 THE CIRCULATING LEVELS OF ENDOGENOUS EICOSAPENTAENOIC ACID AND DOCOSAHEXAENOIC ACID-DERIVED RESOLVINS ARE INCREASED IN SYSTEMIC SCLEROSIS: EVIDENCE FROM A SINGLE CENTRE COHORT

Avanoğlu Güler A., Çoşkun C., Karadeniz H., Gökgöz Acar S., Bilici R., Satış H., et al.

EULAR 2024 , Vienna, Avusturya, 12 Haziran 2024, cilt.83, ss.1930-1931, (Tam Metin Bildiri)

22. AB0394 COMORBIDITIES IN 40.643 PSORIATIC ARTHRITIS PATIENTS ACCORDING TO GENDER: RESULTS FROM E.PULSE, THE NATIONWIDE HEALTH DATA

KALYONCU U., SATIŞ H., AYAN G., BİLGİN E., ERDEN A., ARMAĞAN B., et al.

European Congress of Rheumatology (EULAR) 2024, Viyana, Avusturya, 12 - 15 Haziran 2024, cilt.83, ss.1443-1444, (Özet Bildiri)

23. AB1271 EVALUATION OF SINONASAL INVOLVEMENT IN ANCA-ASSOCIATED VASCULITIS USING THE SNOT-22 QUESTIONNAIRE

baş d., KARDAŞ R. C., YILDIRIM D., KAYA B., VASİ İ., DURAN R., et al.

European Congress of Rheumatology (EULAR) 2024, Viyana, Avusturya, 12 - 15 Haziran 2024, cilt.83, ss.1979, (Özet Bildiri)

24. AB0641 DEMOGRAPHIC CHARACTERISTICS, COMORBIDITIES AND TREATMENT CHOICES OF EARLY AND LATE ONSET RA PATIENTS: RESULTS FROM E.PULSE, THE NATIONWIDE HEALTH DATA

KÜÇÜKŞAHİN O., SATIŞ H., KARABULUT E., AYAN G., ERDEN A., BİLGİN E., et al.

European Congress of Rheumatology (EULAR) 2024, Viyana, Avusturya, 12 - 15 Haziran 2024, cilt.83, ss.1607, (Özet Bildiri)

25. AB0535 ALMOST TWO AND HALF PRECENTAGE OF RA PATIENTS HAD DIFFICULT TO TREAT (D2T): RESULTS FROM E.PULSE, THE NATIONWIDE HEALTH DATA

AYAN G., KARABULUT E., SATIŞ H., ERDEN A., BİLGİN E., ARMAĞAN B., et al.

European Congress of Rheumatology (EULAR) 2024, Viyana, Avusturya, 12 - 15 Haziran 2024, cilt.83, ss.1545, (Özet Bildiri)

26. AB0397 CHARACTERISTICS OF PATIENTS WITH DIFFICULT TO TREAT PSORIATIC ARTHRITIS: RESULTS FROM E.PULSE, THE NATIONWIDE HEALTH DATA

KALYONCU U., SATIŞ H., AYAN G., BİLGİN E., ERDEN A., ARMAĞAN B., et al.

European Congress of Rheumatology (EULAR) 2024, Viyana, Avusturya, 12 - 15 Haziran 2024, cilt.83, ss.1445-1446, (Özet Bildiri)

27. AB0835 CANCER FREQUENCY IN CLOSE RELATIVES OF PATIENTS WITH SJÖGREN’S SYNDROME

Uğur Tuzcu T., KARDAŞ R. C., VASİ İ., YILDIRIM D., KAYA B., DURAN R., et al.

European Congress of Rheumatology (EULAR) 2024, Viyana, Avusturya, 12 - 15 Haziran 2024, cilt.83, ss.1715, (Özet Bildiri)

28. AB1421 DETERMINATION OF THE RELATIONSHIP BETWEEN SERUM PROTEIN 14-3-3 ETA LEVELS AND CLINICAL FEATURES OF THE DISEASE IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER

avcu a., YILDIRIM D., ERDEN A., KÜÇÜK H., TUFAN A., ÖZTÜRK M. A.

European Congress of Rheumatology (EULAR) 2024, Viyana, Avusturya, 12 - 15 Haziran 2024, cilt.83, ss.2066, (Özet Bildiri)

29. AB1327 VALIDATION OF THE 2022 ACR/EULAR CLASSIFICATION CRITERIA FOR LARGE-VESSEL VASCULITIS; CONFUSION OF CLASSIFICATION BETWEEN CERTAIN AGES REMAINS

ÖZDEMİR ULUSOY B., ERDEN A., GÜVEN S. C., ARMAĞAN B., KAYACAN ERDOĞAN E., AKYÜZ DAĞLI P., et al.

European Congress of Rheumatology (EULAR) 2024, Viyana, Avusturya, 12 - 15 Haziran 2024, cilt.83, ss.2012-2013, (Özet Bildiri)

30. POS1514-HPR ASSOCIATION BETWEEN RESPIRATORY MUSCLE ENDURANCE WITH RESPIRATORY MUSCLE STRENGTH, EXERCISE CAPACITY, DYSPNEA, AND FATIGUE IN PATIENTS WITH RHEUMATOID ARTHRITIS

BAYRAM S., VASİ İ., ERDEN A., OSKAY D.

European Congress of Rheumatology (EULAR) 2024, Viyana, Avusturya, 12 - 15 Haziran 2024, cilt.83, ss.1185-1186, (Özet Bildiri)

31. OP0175 COMORBIDITIES IN 347.902 RHEUMATOID ARTRITIS PATIENTS ACCORDING TO GENDER: RESULTS FROM E.PULSE, THE NATIONWIDE HEALTH DATA

KÜÇÜKŞAHİN O., SATIŞ H., KARABULUT E., AYAN G., ERDEN A., BİLGİN E., et al.

European Congress of Rheumatology (EULAR) 2024, Viyana, Avusturya, 12 - 15 Haziran 2024, cilt.83, ss.76-77, (Özet Bildiri)

32. AB1016 SERUM CXCL-13 LEVELS ARE ASSOCIATED WITH ACTIVE NEUROLOGICAL INVOLVEMENT IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

TUFAN A., YILDIRIM D., koç kanık h. n., DURAN R., KARDAŞ R. C., KAYA B., et al.

European Congress of Rheumatology (EULAR) 2024, Viyana, Avusturya, 12 - 15 Haziran 2024, cilt.83, ss.1826, (Özet Bildiri)

33. AB0041 EVALUATING DISEASE ACTIVITY AND CARDIOVASCULAR RISK USING BIOMARKERS IN FAMILIAL MEDITERRANEAN FEVER PATIENTS

YAZ AYDIN G., KARDAŞ R. C., VASİ İ., Altınsoy M. C., ERDEN A., KÜÇÜK H., et al.

European Congress of Rheumatology (EULAR) 2024, Viyana, Avusturya, 12 - 15 Haziran 2024, cilt.81, ss.1247, (Özet Bildiri)

34. VENOUS THROMBOEMBOLISM IN ANCA-ASSOCIATED VASCULITIS MIGHT BE ASSOCIATED WITH DISEASE ACTIVITY: RESULTS OFTR-VaS COHORT

KOCAAYAN H., Durak Ediboğlu E., Demirci Yıldırım T., ÖZDEMİR B., Öğüt T. S., FIRLATAN B., et al.

Meeting of the European-Alliance-of-Associations-for-Rheumatology (EULAR), Vienna, Avusturya, 12 - 15 Haziran 2024, cilt.83, (Özet Bildiri) Sürdürülebilir Kalkınma

35. REMARKING THE OSTEOPOROSIS IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS (AAV): DATA FROM EASTERN MEDITERRANEAN (TRVAS)

Demirci Yıldırım T., ERPEK KARAOVA E., ÖZDEMİR ULUSOY B., ÜNALDI E., SADİOĞLU ÇAĞDAŞ Ö., KARDAŞ R. C., et al.

European Congress of Rheumatology, Vienna, Avusturya, 12 - 15 Haziran 2024, cilt.83, (Özet Bildiri) Sürdürülebilir Kalkınma

36. Moyamoya sendromu ve antifosfolipid antikor sendromu birlikteliği

VASİ İ., KARDAŞ R. C., YILDIRIM D., KAYA B., DURAN R., ERDEN A., et al.

23. ULUSAL ROMATOLOJİ KONGRESİ 2023, Antalya, Türkiye, 11 - 15 Ekim 2023, cilt.15, ss.201, (Tam Metin Bildiri)

37. IGG4 ilişkili hastalıkta klinik fenotiplendrime ve yanıt değerlendirme: Tek merkez deneyimi

KARDAŞ R. C., YILDIRIM D., KAYA B., VASİ İ., DURAN R., ERDEN A., et al.

23. ULUSAL ROMATOLOJİ KONGRESİ 2023, Antalya, Türkiye, 11 - 15 Ekim 2023, cilt.15, ss.144, (Tam Metin Bildiri)

38. Ailevi Akdeniz Ateşi hastalarında serum protein 14-3- 3 eta düzeyi ile hastalığın klinik özellikleri arasındaki ilişkinin belirlenmes

Avcu A., YILDIRIM D., ERDEN A., KÜÇÜK H., GÖKER B., ÖZTÜRK M. A., et al.

Ulusal Romatoloji Kongresi, Antalya, Türkiye, 11 Ekim 2023, (Tam Metin Bildiri)

39. Vaskülit ve bağ doku hastalıkları ayırıcı tanısında nadir görülen bir olgu

KAYA B., YILDIRIM D., VASİ İ., KARDAŞ R. C., DURAN R., KÜÇÜK H., et al.

Ulusal Romatoloji Kongresi, Antalya, Türkiye, 11 - 15 Ekim 2023, (Tam Metin Bildiri)

40. Ulusal dev hücreli arterit veritabanı izlem verisi: Relaps oranı kontrollü çalışmalardan düşüktür

ALİBAZ ÖNER F., KELEŞOĞLU DİNÇER A. B., BALCI M. A., YARDIMCI G. K., ARMAĞAN B., KILIÇ L., et al.

Ulusal Romatoloji Kongresi, Antalya, Türkiye, 11 - 15 Ekim 2023, (Tam Metin Bildiri)

41. Sistemik skleroz hastalarında SARS-COV-2 enfeksiyonun klinik özellikleri ve hastalık seyr

AVANOĞLU GÜLER A., VASİ İ., ÖZÇİMEN B., AYDOĞDU M. S., SARI A., Aliyeva N., et al.

Ulusal Romatoloji Kongresi, Antalya, Türkiye, 11 - 15 Ekim 2023, (Tam Metin Bildiri)

42. Dirençli kutanöz ülserlerle seyreden bir anti MDA-5 pozitif dermatomiyozit olgusu

DURAN R., ERDEN A., KÜÇÜK H.

Ulusal Romatoloji Kongresi, Antalya, Türkiye, 11 - 15 Ekim 2023, (Tam Metin Bildiri)

43. Kolşisin intoleran Ailevi Akdeniz Ateşi hastalarında IL-1 antagonistinin monoterapi kullanımı ile etkin tedavi mümkün mü?

YILDIRIM D., KAYA B., VASİ İ., KARDAŞ R. C., DURAN R., KARADENİZ H., et al.

Ulusal Romatoloji Kongresi, Antalya, Türkiye, 11 Ekim 2023, (Tam Metin Bildiri)

44. Still hastalığı ve enflamatuvar miyozitlerde PET’te dalak ortalama SUV değeri ile makrofaj aktivasyon sendromu riskinin ve mortalitenin değerlendirilmes

Zelyurt N., KARDAŞ R. C., YILDIRIM D., KAYA B., VASİ İ., DURAN R., et al.

Ulusal Romatoloji Kongresi, Antalya, Türkiye, 11 Ekim 2023, (Tam Metin Bildiri)

45. Psoriasisli ve psöriatik artritli hastalarda serum CXCL13 düzeylerinin karşılaşt

YILDIRIM D., BAYKUL M., VASİ İ., GÜLENGÜL M., EDEK Y. C., KÜÇÜK H., et al.

Ulusal Romatoloji Kongresi, Antalya, Türkiye, 11 Ekim 2023, (Tam Metin Bildiri)

46. Anti sentetaz sendromunun klinik progresyonunda nadir bir sebep: Kızamık pnömonisi

Bozer M. N., Bozkurt H. H., ERDEN A., KÜÇÜK H.

Ulusal Romatoloji Kongresi, Antalya, Türkiye, 11 - 15 Ekim 2023, (Tam Metin Bildiri)

47. VEXAS sendromunda adalimumab kullanımı: Tek merkez deneyimi

KARDAŞ R. C., ERDEN A., KÜÇÜK H.

Ulusal Romatoloji Kongresi, Antalya, Türkiye, 11 - 15 Ekim 2023, (Tam Metin Bildiri)

48. 2023 ACR/EULAR antifosfolipid antikor sendromu sınıflandırma kriterlerinin antifosfolipid antikoru pozitif hasta kohortundaki performansı

KARDAŞ R. C., VASİ İ., YILDIRIM D., KAYA B., DURAN R., ERDEN A., et al.

Ulusal Romatoloji Kongresi, Antalya, Türkiye, 11 - 15 Ekim 2023, (Tam Metin Bildiri)

49. Spondiloartritlerin tedavisinde biyolojik DMARD sonrası tedavi seçimi

İŞBİLİR G. D., KARDAŞ R. C., YILDIRIM D., KAYA B., VASİ İ., DURAN R., et al.

Ulusal Romatoloji Kongresi, Antalya, Türkiye, 11 - 15 Ekim 2023, (Tam Metin Bildiri)

50. Lupus nefriti ve renal tutulumlu sistemik vaskülitlerde SGLT2 inhibitörü kullanımı: Tek merkez deneyimi

KARDAŞ R. C., YILDIRIM D., KAYA B., VASİ İ., DURAN R., ERDEN A., et al.

Ulusal Romatoloji Kongresi, Antalya, Türkiye, 11 - 15 Ekim 2023, (Tam Metin Bildiri)

51. IGG4 ilişkili hastalık ve çoklu malignite birlikteliği olan 2 olgu sunumu

DURAN R., ERDEN A., KÜÇÜK H.

Ulusal Romatoloji Kongresi, Antalya, Türkiye, 11 - 15 Ekim 2023, (Tam Metin Bildiri)

52. Serum high mobility box protein 1 (HMGB-1) düzeylerinin psoriasisli ve psöriatik artritli hastalar arasında karşılaştırılması

YILDIRIM D., BAYKUL M., AVANOĞLU GÜLER A., EDEK Y. C., GÜLENGÜL M., ADIŞEN E., et al.

Ulusal Romatoloji Kongresi, Antalya, Türkiye, 11 - 15 Ekim 2023, (Tam Metin Bildiri)

53. Moyamoya sendromu ve antifosfolipid antikor sendromu birlikteliğ

VASİ İ., KARDAŞ R. C., YILDIRIM D., KAYA B., DURAN R., ERDEN A., et al.

Ulusal Romatoloji Kongresi, Antalya, Türkiye, 11 Ekim 2023, (Tam Metin Bildiri)

54. GG4 ilişkili hastalıkta klinik fenotiplendrime ve yanıt değerlendirme: Tek merkez deneyimi

KARDAŞ R. C., YILDIRIM D., KAYA B., VASİ İ., DURAN R., ERDEN A., et al.

Ulusal Romatoloji Kongresi, Antalya, Türkiye, 11 - 15 Ekim 2023, (Tam Metin Bildiri)

55. Vaskülit ile karışabilen nadir bir durum; prolidaz enzim eksikliğ

Bozkurt H. H., Bozer M. N., YILDIRIM D., ERDEN A., KÜÇÜK H.

Ulusal Romatoloji Kongresi, Antalya, Türkiye, 11 - 15 Ekim 2023, (Tam Metin Bildiri)

56. Peroksiredoksin-4: Sistemik skleroz ilişkili interstisyel akciğer hastalığında yeni bir biyomarker olabilir mi?

Alp G. T., VASİ İ., AVANOĞLU GÜLER A., KARADENİZ H., ERDEN A., KÜÇÜK H., et al.

Ulusal Romatoloji Kongresi, Antalya, Türkiye, 11 Ekim 2023, (Tam Metin Bildiri)

57. COMPARISON OF SERUM CXCL13 LEVELS BETWEEN PATIENTS WITH PSORIASIS AND PSORIATIC ARTHRITIS

YILDIRIM D., VASİ İ., BAYKUL M., Gülengül M., Erdek Y., KÜÇÜK H., et al.

EULAR (Avrupa Romatoloji Kongresi), Milan, İtalya, 31 Mayıs 2023, (Tam Metin Bildiri)

58. L MARKER IN SYSTEMIC SCLEROSISASSOCIATED INTERSTITIAL LUNG DISEASE: PEROXIREDOXIN-4

Alp G. T., KARADENİZ H., VASİ İ., AVANOĞLU GÜLER A., ERDEN A., KÜÇÜK H., et al.

EULAR (Avrupa Romatoloji Kongresi), Milan, İtalya, 31 Mayıs 2023, (Tam Metin Bildiri)

59. PERFORMANCE OF 2022 ACR/EULAR GPA, EGPA AND MPA CLASSIFICATION CRITERIA IN TURKISH VASCULITIS STUDY GROUP PROSPECTIVE COHORT (TRVAS)

BÖLEK E. Ç., AYAN G., BİLGİN E., KÜÇÜK H., ERDEN A., ALİBAZ ÖNER F., et al.

EULAR (Avrupa Romatoloji Kongresi), Milan, İtalya, 31 Mayıs 2023, (Tam Metin Bildiri)

60. COLCHICINE INTOLERANT FAMILIAL MEDITERRANEAN FEVER PATIENTS RECEIVING IL-1 ANTAGONISTS: DO THEY MISS ADVANTAGE OF COMBINATION

YILDIRIM D., Özkızıltaş B., VASİ İ., KARDAŞ R. C., DURAN R., KARADENİZ H., et al.

EULAR (Avrupa Romatoloji Kongresi), Milan, İtalya, 31 Mayıs - 03 Haziran 2023, (Tam Metin Bildiri)

61. CLINICAL CHARACTERISTICS AND CLINICAL OUTCOME OF SYSTEMIC SCLEROSIS OVERLAP SYNDROME (SSC-OS) IN TURKISH PATIENTS WITH SYSTEMIC SCLEROSIS

VASİ İ., KARDAŞ R. C., Ozkiziltas B., YILDIRIM D., Alp G. T., AVANOĞLU GÜLER A., et al.

EULAR (Avrupa Romatoloji Kongresi), Milan, İtalya, 31 Mayıs 2023, (Tam Metin Bildiri)

62. CHOICE OF BDMARD AFTER TNFI: DOES IT MATTER IN THE TREATMENT OF SPONDYLOARTHRITIS

İŞBİLİR G. D., KARDAŞ R. C., YILDIRIM D., Özkızıltaş B., VASİ İ., DURAN R., et al.

EULAR (Avrupa Romatoloji Kongresi), Milan, İtalya, 31 Mayıs 2023, (Tam Metin Bildiri)

63. AB0922 CLINICAL CHARACTERISTICS AND CLINICAL OUTCOME OF SYSTEMIC SCLEROSIS OVERLAP SYNDROME (SSC-OS) IN TURKISH PATIENTS WITH SYSTEMIC SCLEROSIS

VASİ İ., KARDAŞ R. C., DURAN R., Özkızıltaş B., YILDIRIM D., ALP G. T., et al.

European Congress of Rheumatology (EULAR) 2023, Milan, İtalya, 31 Mayıs - 03 Haziran 2023, cilt.82, ss.1678, (Özet Bildiri)

64. POS0923 THE TRANSITION FROM ACTIVE LESIONS TO STRUCTURAL CHANGES ON SACROILIAC MRI AND ITS ASSOCIATED FACTORS

KALYONCU U., AYAN G., KILIÇ L., ATAGÜNDÜZ M. P., AKAR S., YAŞAR BİLGE N. Ş., et al.

European Congress of Rheumatology (EULAR) 2023, Milan, İtalya, 30 Mayıs - 03 Haziran 2023, cilt.82, ss.773, (Özet Bildiri)

65. AB1461 COLCHICINE INTOLERANT FAMILIAL MEDITERRANEAN FEVER PATIENTS RECEIVING IL-1 ANTAGONISTS: DO THEY MISS ADVANTAGE OF COMBINATION

YILDIRIM D., Özkızıltaş B., VASİ İ., KARDAŞ R. C., DURAN R., KARADENİZ H., et al.

European Congress of Rheumatology (EULAR) 2023, Milan, İtalya, 31 Mayıs - 03 Haziran 2023, cilt.82, ss.1958-1959, (Özet Bildiri)

66. AB1014 RADIOGRAPHIC VERSUS NON-RADIOGRAPHIC AXIAL SPONDYLOARTHRITIS: RESULTS FROM TREASURE DATABASE

KILIÇ L., AYAN G., ATAGÜNDÜZ M. P., AKAR S., YAŞAR BİLGE N. Ş., DALKILIÇ H. E., et al.

European Congress of Rheumatology (EULAR) 2023, Milan, İtalya, 31 Mayıs - 03 Haziran 2023, cilt.82, ss.1728-1729, (Özet Bildiri)

67. AB0940 TITLE: CHOICE OF BDMARD AFTER TNFI: DOES IT MATTER IN THE TREATMENT OF SPONDYLOARTHRITIS?

İŞBİLİR G. D., KARDAŞ R. C., YILDIRIM D., Özkızıltaş B., VASİ İ., DURAN R., et al.

European Congress of Rheumatology (EULAR) 2023, Milan, İtalya, 31 Mayıs - 03 Haziran 2023, cilt.82, ss.1687-1688, (Özet Bildiri)

68. POS0879 THE IMPACT OF 6-MONTH DELAY IN DIAGNOSIS ON CLINICAL AND FUNCTIONAL STATUS IN THE PSA PATIENTS UNDER BDMARD TREATMENT: RESULTS FROM TREASURE DATABASE

AYAN G., KILIÇ L., YAŞAR BİLGE N. Ş., ATAGÜNDÜZ M. P., DALKILIÇ H. E., PEHLİVAN Y., et al.

European Congress of Rheumatology (EULAR) 2023, Milan, İtalya, 31 Mayıs - 03 Haziran 2023, cilt.82, ss.745-746, (Özet Bildiri)

69. AB0845 A NOVEL MARKER IN SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: PEROXIREDOXIN-4

ALP G. T., KARADENİZ H., VASİ İ., AVANOĞLU GÜLER A., ERDEN A., KÜÇÜK H., et al.

European Congress of Rheumatology (EULAR) 2023, Milan, İtalya, 31 Mayıs - 03 Haziran 2023, cilt.82, ss.1635-1636, (Özet Bildiri)

70. AB1763-HPR RELIABILITY AND VALIDITY OF THE TURKISH VERSION OF SCLERODERMA SKIN PATIENT-REPORTED OUTCOME IN PATIENTS WITH SYSTEMIC SCLEROSIS

SARİ F., BAZANCİR APAYDIN Z., APAYDIN H., kayaalp m., ERDEN A., GÜVEN S. C., et al.

European Congress of Rheumatology (EULAR) 2023, Milan, İtalya, 31 Mayıs - 03 Haziran 2023, cilt.82, ss.2114-2115, (Özet Bildiri)

71. AB0701 PERFORMANCE OF DRAFT 2022 ACR/EULAR CLASSIFICATION CRITERIA IN A TURKISH COHORT OF APL ANTIBODY POSITIVE PATIENTS

KARDAŞ R. C., YILDIRIM D., Özkızıltaş B., VASİ İ., DURAN R., KARADENİZ H., et al.

European Congress of Rheumatology (EULAR) 2023, Milan, İtalya, 31 Mayıs - 03 Haziran 2023, cilt.82, ss.1554, (Özet Bildiri)

72. AB1691 BURDEN OF AFFECTED FACE IN PATIENTS WITH SYSTEMIC SCLEROSIS: A TRANSLATION AND VALIDATION STUDY IN TURKISH

SARİ F., BAZANCİR APAYDIN Z., APAYDIN H., kayaalp m., ERDEN A., GÜVEN S. C., et al.

European Congress of Rheumatology (EULAR) 2023, Milan, İtalya, 30 Mayıs - 03 Haziran 2023, cilt.82, (Özet Bildiri)

73. PP-019 ÜLKE ÇAPINDA BİR ÇALIŞMA ROMATOİD FAKTÖR VE ANTİ-SİTRÜLİNE PEPTİT POZİTİFLİĞİNİN PREVALANSI VE ROMATOİD ARTRİT TANISINA KATKILARI

SATIŞ H., ERDEN A., BİLGİN E., AYAN G., ARMAĞAN B., TECER D., et al.

Ulusal Romatoloji Dergisi XXII. Ulusal Romatoloji Kongresi Bildiri Özetleri, Türkiye, 26 - 30 Ekim 2022, (Özet Bildiri)

74. Anne sütü alımı behçet hastalığına eşlik eden komorbidite ve sakroiliit sıklığını etkiler mi?

Konak H. E., ERDEN A., ARMAĞAN B., GÜVEN S. C., APAYDIN H., AKYÜZ DAĞLI P., et al.

XXII. Ulusal Romatoloji Kongresi, Antalya, Türkiye, 26 Ekim 2022, cilt.14, ss.114, (Tam Metin Bildiri)

75. Behçet hastalarında vasküler tutulumda erektil disfonksiyon

Polat B., ERDEN A., ÜNAL S., ARMAĞAN B., GÜVEN S. C., OKULU E., et al.

XXII. Ulusal Romatoloji Kongresi, Antalya, Türkiye, 26 Ekim 2022, cilt.14, ss.183-184, (Tam Metin Bildiri)

76. A SINGLE CENTER COVID-19 VACCINE EXPERIENCE IN FAMILIAL MEDITERRANEAN FEVER PATIENTS

GÜVEN S. C., KARAKAŞ Ö., ATALAR E., Konak H. E., AKYÜZ DAĞLI P., KAYACAN ERDOĞAN E., et al.

EULAR 2022 – Annual European Congress of Rheumatology, Danimarka, 1 - 04 Haziran 2022, ss.973-974, (Özet Bildiri)

77. Does breastfeeding affect the frequency of comorbidity and sacroiliitis accompanying Behçet's disease?

KONAK H. E., ERDEN A., ARMAĞAN B., GÜVEN S. C., APAYDIN H., AKYÜZ DAĞLI P., et al.

EULAR 2022, KOPENHAG, Danimarka, 01 Haziran 2022, (Özet Bildiri)

78. THE DIFFERENCES BETWEEN THE FIRST PREFERRED BIOLOGICAL DMARD AND THE DRUG SURVIVAL IN GERIATRIC AND YOUNGER ADULT POPULATION WITH RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS: TREASURE REAL-LIFE DATA

GÖNÜLLÜ E., KALYONCU U., YAĞIZ B., ATEŞ A., KÜÇÜKŞAHİN O., YAŞAR BİLGE N. Ş., et al.

The Annual European Congress of Rheumatology EULAR 2022, 01 Haziran 2022, (Özet Bildiri)

79. GRANÜLOMATÖZ POLİANJİİT HASTALARINDA YAŞAM KALİTESİ VE İLİŞKİLİ FAKTÖRLER

AKYÜZ DAĞLI P., GÜVEN S. C., ERDEN A., EKSİN M. A., ARMAĞAN B., KÜÇÜKŞAHİN O., et al.

15. Anadolu Romatoloji Günleri, Girne, Kıbrıs (Kktc), 25 - 29 Mayıs 2022, (Özet Bildiri)

80. AB0766 Biologic Drug Preferences of Turkish Rheumatologists in Spondiloartropathy Patients with Advanced Chronic Renal Disease

MERCAN R., tezcan m. e., YAĞIZ B., ATEŞ A., KÜÇÜKŞAHİN O., YAŞAR BİLGE N. Ş., et al.

EULAR- Annual European Congress of Rheumatology, 2022, Copenhagen, Danimarka, 01 Haziran 2022, cilt.81, ss.1509-1510, (Tam Metin Bildiri)

81. AB0355 THE DIFFERENCES BETWEEN THE FIRST PREFERRED BIOLOGICAL DMARD AND THE DRUG SURVIVAL IN GERIATRIC AND YOUNGER ADULT POPULATION WITH RHEUMATOID ARTHRITIS AND PSORIATIC ARTHRITIS: TREASURE REAL-LIFE DATA

GÖNÜLLÜ E., KALYONCU U., YAĞIZ B., ATEŞ A., KÜÇÜKŞAHİN O., YAŞAR BİLGE N. Ş., et al.

EULAR- Annual European Congress of Rheumatology, 2022, Copenhagen, Danimarka, 01 Haziran 2022, cilt.81, ss.1304, (Tam Metin Bildiri)

82. AB1175 EFFECTS OF THE COVID-19 DISEASE ON AXIAL SPONDYLOARTHRITIS DISEASE FLARE

ARMAĞAN B., ATALAR E., ÖZDEMİR B., KAYACAN ERDOĞAN E., GÜVEN S. C., DOĞAN İ., et al.

EULAR- Annual European Congress of Rheumatology, 2022, kopenhag, Danimarka, 01 Haziran 2022, cilt.81, ss.1702-1703, (Tam Metin Bildiri)

83. POS1250 EVALUATION AFTER COVID-19 VACCINATION IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME: A RETROSPECTIVE COHORT STUDY.

KARAKAŞ Ö., ERDEN A., ARMAĞAN B., GÜVEN S. C., ATALAR E., Polat B., et al.

EULAR- Annual European Congress of Rheumatology, 2022, kopenhag, Danimarka, 01 Haziran 2022, cilt.81, ss.960, (Tam Metin Bildiri)

84. POS1280 EFFECTS OF ANTI-SARS-CoV-2 VACCINATION ON SAFETY AND DISEASE EXACERBATION IN BEHCET’S DISEASE PATIENTS: A SINGLE CENTRE STUDY

APAYDIN H., ERDEN A., ARMAĞAN B., GÜVEN S. C., Konak H. E., Afşin Y., et al.

EULAR- Annual European Congress of Rheumatology, 2022, Copenhagen, Danimarka, 01 Haziran 2022, cilt.81, ss.977, (Tam Metin Bildiri)

85. POS1184 EPIDEMIOLOGICAL CHARACTERISTICS OF VIRAL HEPATITIS IN PATIENTS WITH RHEUMATIC DISEASES – IMPLICATIONS FROM TREASURE DATABASE

ERSÖZLÜ E. D., EKİCİ M., COŞKUN B. N., BADAK S. Ö., BİLGİN E., KALYONCU U., et al.

EULAR- Annual European Congress of Rheumatology, 2022, Copenhagen, Danimarka, 01 Haziran 2022, cilt.81, ss.919-920, (Tam Metin Bildiri)

86. EVALUATION AFTER COVID-19 VACCINATION IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME: A RETROSPECTIVE COHORT STUDY

KARAKAŞ Ö., ERDEN A., ARMAĞAN B., GÜVEN S. C., ATALAR E., Polat B., et al.

EULAR 2022 – Annual European Congress of Rheumatology, Danimarka, 01 Haziran 2022, (Özet Bildiri)

87. AB1142 EFFECTS OF SULFASALAZINE USED IN AXIAL SPONDYLOARTHRITIS ON COVID-19 OUTCOMES: REAL-LIFE DATA FROM A SINGLE CENTER

ARMAĞAN B., ATALAR E., GÜVEN S. C., ÖZDEMİR B., Konak H. E., AKYÜZ DAĞLI P., et al.

EULAR – Annual European Congress of Rheumatology, 2022, kopenhag, Danimarka, 01 Haziran 2022, cilt.81, ss.1688, (Tam Metin Bildiri)

88. POS1274 A SINGLE CENTER COVID-19 VACCINE EXPERIENCE IN FAMILIAL MEDITERRANEAN FEVER PATIENTS

GÜVEN S. C., KARAKAŞ Ö., ATALAR E., Konak H. E., AKYÜZ DAĞLI P., KAYACAN ERDOĞAN E., et al.

EULAR- Annual European Congress of Rheumatology, 2022, Copenhagen, Danimarka, 01 Haziran 2022, cilt.81, ss.973-974, (Özet Bildiri)

89. Multipl skleroza eşlik eden psöriyatik artrit veya ankilozan spondilit varlığında sekukinumab bir tedavi seçeneği olabilir mi? Literatür taraması eşliğinde olgu serisi

EKSİN M. A., ERDEN A., GÜVEN S. C., ARMAĞAN B., ÖZDEMİR B., karakaş ö., et al.

XXI. Ulusal Romatoloji Kongresi, Türkiye, 29 Eylül - 03 Ekim 2021, (Özet Bildiri)

90. Periaortitis and Coronary Arteritis in IgG4-Related Disease:Eastern Mediterranean Experience

YARDIMCI G. K., SARI A., ERDEN A., BÖLEK E. Ç., FARİSOĞULLARI B., KILIÇ L., et al.

American College of Rheumatology, ACR Convergence-2019, Amerika Birleşik Devletleri, 9 - 13 Kasım 2019, (Özet Bildiri)

91. Periaortitis and Coronary Arteritis in IgG4-Related Disease: Eastern Mediterranean Experience

Yardimci G. K., Sari A., ERDEN A., BÖLEK E. Ç., Farisogullari B., KILIÇ L., et al.

Annual Meeting of the American-College-of-Rheumatology/Association-of-Rheumatology-Professionals (ACR/ARP), Georgia, Amerika Birleşik Devletleri, 8 - 13 Kasım 2019, cilt.71, (Özet Bildiri)

92. OP0168 DERIVATION AND VALIDATION OF A NEW STILL ACTIVITY SCORE (SAS)

KALYONCU U., KAŞİFOĞLU T., omma a., BES C., ÇINAR M., EMMUNGİL H., et al.

Oral Presentations, 12 - 15 Haziran 2019, (Tam Metin Bildiri)

93. AB0574 A MONOGENIC DISEASE WITH WIDE RANGE OF SYMPTOMS: DEFICIENCY OF ADENOSINE DEAMINASE 2

BATU AKAL E. D., TAŞKIRAN Z. E., ÖZKARA H. A., ÜNAL CANGÜL Ş., ERDEN A., KARADAĞ Ö., et al.

Annual European congress of rheumatology EULAR 2019, Madrid 12-15 june 2019, Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.1748, (Özet Bildiri)

94. IS THERE AN OVERLAP OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIDES WITH IGG4-RELATED DISEASE OR NOT?

ERDEN A., BÖLEK E. Ç., Yardimci G. K., Bilgen S. A., KARADAĞ Ö.

Annual European Congress of Rheumatology (EULAR), Madrid, İspanya, 12 - 15 Haziran 2019, cilt.78, ss.990, (Özet Bildiri)

95. Sistemik Lupus Eritematozus’un Tedavisi ve İzlemi

ERDEN A.

Sağlık Bilimleri Üniversitesi 2. Romatizmal Hastalıklar Sempozyumu, Türkiye, 22 - 23 Mart 2019, (Tam Metin Bildiri)

96. Meme kanserli hastalarda hastalıksız ve genel sağkalım Analizi

ERDEN A.

6. İYİ KLİNİSYENLİK İÇİN İPUÇU TOPLANTISI, Türkiye, 18 - 20 Ocak 2019, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

97. Treatment Choices and Response Rates of SAPHO Syndrome:Single Center Case Series

ERDEN A., EKİCİ M., SARI A., ARMAĞAN B., KILIÇ L., APRAŞ BİLGEN Ş. Ş., et al.

2018 ACR/ARHP Annual Meeting, 20 - 24 Ekim 2018, (Tam Metin Bildiri)

98. Kapilleroskopide Skorlama

ERDEN A.

4. Aydın Romatoloji Günleri, Türkiye, 12 - 14 Ekim 2018, (Tam Metin Bildiri)

99. Clinical Features and Disease Course of Neurologic Involvement in Behcet’s Disease

BÖLEK E. Ç., SARI A., ARMAĞAN B., ERDEN A., KILIÇ L., KALYONCU U., et al.

American College of Rheumatology, ACR Convergence-2018, CHİCAGO, Amerika Birleşik Devletleri, 19 - 24 Ekim 2018, (Özet Bildiri)

100. Psoriyatik artritte mortalitede artışı saptanmamıştır: Ulusal psoriyatik artrit kohortu (PSART) verileri

ERDEN A., KILIÇ L., SOLMAZ D., bakırcı s., KİMYON G., kasapoğlu günal e., et al.

19.ULUSAL ROMATOLOJİ KONGRESİ, Türkiye, 26 - 30 Eylül 2018, (Tam Metin Bildiri)

101. Erişkin başlangıçlı Still hastalığının diğer nedeni bilinmeyen ateş etyolojilerinden ayrımında ferritin için farklı kestirim değerlerinin karşılaştırılması: Tek merkezli, prospektif çalışma sonuçları

BİLGİN E., ERDEN A., ARMAĞAN B., SARI A., YARDIMCI G. K., FARİSOĞULLARI B., et al.

XIX. Ulusal Romatoloji Kongresi, Muğla, Türkiye, 26 - 30 Eylül 2018, (Özet Bildiri)

102. Psoriyatik artritte mortalitede artışı saptanmamıştır.Ulusal psoriyatik artrit kohortu (PSART) verileri

ERDEN A., KILIÇ L., SOLMAZ D., BAKIRCI S., Kimyon G., Kasapoglu G. E., et al.

19. Ulusal Romatoloji Kongresi, BODRUM, Türkiye, 26 - 30 Eylül 2018, cilt.10, (Özet Bildiri)

103. Four years of delay in the diagnosis of sapho syndrome: single tertiary centre experience

ERDEN A., EKİCİ M., ARMAĞAN B., SARI A., YARDIMCI G. K., KILIÇ L., et al.

EULAR 2018, Spondyloarthritis – clinical aspects (other than treatment), İspanya, 13 - 16 Haziran 2018, (Tam Metin Bildiri)

104. TAKAYASU ARTERİTİ HASTALARINDA PULMONER HİPERTANSİYON SIKLIĞI VE NEDENLERİ

SARI A., ŞENER Y. Z., FIRAT E., ARMAĞAN B., OKŞUL M., KILIÇ L., et al.

2. ULUSAL ADHAD KONGRESİ, BODRUM, Türkiye, 26 - 29 Nisan 2018, (Özet Bildiri)

105. Behcet Disease Frequency Among People with Visual Loss

ERDEN A., KILIÇ L., KARADAĞ Ö., KALYONCU U.

International Internal Medicine Training Meeting-12, 23 - 25 Şubat 2018, (Tam Metin Bildiri)

106. Behçet Hastalığında-Tromboz Antikoagülasyon kullanalım mı

ERDEN A.

5. İyi Klinisyenlik İçin İpuçları Toplantısı, Türkiye, 19 - 21 Ocak 2018, (Tam Metin Bildiri)

107. ANKİLOZAN SPONDİLİTTE EKLEM MOBİLİTESİNİN BİREYLERİN SAĞLIK ALGISINA ETKİSİNİN İNCELENMESİ

ARIN G., TÜRKMEN N. B., OFLAZ F. B., ERDEN A., KARADAĞ Ö., GÖKSÜLÜK D., et al.

3.Ulusal Romatolojik Rehabilitasyon Kongresi, Türkiye, 6 - 08 Ekim 2017, cilt.4, (Özet Bildiri)

108. Starting of Biological Dmards May be Postponed in RA Patients with Multimorbidity: Single Centre Real Life Results

ARMAĞAN B., SARI A., ERDEN A., KILIÇ L., ERDAT E. C., KARADAĞ Ö., et al.

American College of Rheumatology, ACR Convergence-2017, Amerika Birleşik Devletleri, 3 - 08 Kasım 2017, (Özet Bildiri)

109. A Retrospective Study Comparing the Phenotype and Outcomes of Patients with Polyarteritis Nodosa between UK and Turkish Cohorts

KARADAĞ Ö., ERDEN A., BİLGİNER Y., GOPALUNI S., SARI A., ARMAĞAN B., et al.

American College of Rheumatology, ACR Convergence-2017, Amerika Birleşik Devletleri, 3 - 08 Kasım 2017, (Özet Bildiri)

110. Pregnancy Outcomes in Male Patients Using Anti-Tumor Necrosis Factor Alpha Patients with Inflammatory Arthritis Hur-BIO Real Life Experiences

UYAROĞLU O. A., ŞEYHOĞLU E., ERDEN A., KILIÇ L., ARMAĞAN B., SARI A., et al.

2017 ACR/ARHP Annual Meeting, 3 - 08 Kasım 2017, (Özet Bildiri)

111. Older Age and Male Gender Are Independent Predictors of Quantiferon Positivity Among Adult Rheumatic Patients in a Tertiary Care Center from a BCG Vaccinated Country: Hur-BIO Single Center Real Life Results

ŞEYHOĞLU E., UYAROĞLU O. A., ERDEN A., KILIÇ L., ARMAĞAN B., SARI A., et al.

2017 ACR/ARHP Annual Meeting, 3 - 08 Kasım 2017, (Özet Bildiri)

112. Which Definition Should be Used to Determine Colchicine Resistance in Patients with Familial Mediterranean Fever?

ERDEN A., BATU E. D., SARI A., SÖNMEZ H. E., ARMAĞAN B., FIRAT E., et al.

American College of Rheumatology, ACR Convergence-2017, Amerika Birleşik Devletleri, 3 - 08 Kasım 2017, (Özet Bildiri)

113. Patients with Ankylosing Spondylitis Had Better Adalimumab Survival Than Patients with Non-Radiographic Axial Spondyloarthritis

SARI A., ARMAĞAN B., ERDEN A., KILIÇ L., KARADAĞ Ö., AKDOĞAN A., et al.

American College of Rheumatology, ACR Convergence-2017, Amerika Birleşik Devletleri, 3 - 08 Kasım 2017, (Özet Bildiri)

114. Requirement and Response Rates of Biologic Agents in Polyarteritis Nodosa (PAN)

KARADAĞ Ö., ERDEN A., ARMAĞAN B., SARI A., gopaluni p., ERTENLİ A. İ., et al.

ACR 2017, 5 - 10 Kasım 2017, cilt.69, (Özet Bildiri)

115. Ailesel Akdeniz ateşi hastalarinda “A” kan grubu sıklığı artmıştır ve “0” kan grubu kolşisin direnci ile ilişkili olabilir

ERDEN A., BATU AKAL E. D., ARMAĞAN B., SÖNMEZ H. E., SARI A., DEMİR S., et al.

XVIII. Ulusal Romatoloji Kongresi, Antalya, Türkiye, 18 - 22 Ekim 2017, (Özet Bildiri)

116. SAPHO sendromunun tedavisi ve cevap oranları:Olgu serisi

ERDEN A., SARI A., Armagan B., EKİCİ M., KILIÇ L., APRAŞ BİLGEN Ş. Ş., et al.

XVIII. Ulusal Romatoloji Kongresi, Antalya, Türkiye, 18 - 22 Ekim 2017, cilt.9, ss.169-170, (Özet Bildiri)

117. Inflamatuar artrit hastalarında bağımsızlık durumunun değerlendirlmesi

Armagan B., SARI A., ERDEN A., KILIÇ L., Erdat E. C., KARADAĞ Ö., et al.

XVIII. Ulusal Romatoloji Kongresi, Antalya, Türkiye, 18 - 22 Ekim 2017, cilt.9, ss.77, (Özet Bildiri)

118. Biyolojik tedavi öncesi latent tüberküloz taramasında quantiferon tüp testi kullanılan yetişkin romatoloji hastalarında aktif tüberküloz infeksiyonu gelişme sıklığı: HÜR-BİO gerçek yaşam verileri

ŞEYHOĞLU E., UYAROĞLU O. A., ERDEN A., KILIÇ L., ARMAĞAN B., SARI A., et al.

XVIII. Ulusal Romatoloji Kongresi - 2017, Antalya, Türkiye, 18 - 22 Ekim 2017, cilt.9, ss.2-3, (Özet Bildiri)

119. Active Disease Is Associated with Dependency in Inflammatory Arthritis

ÖZTÜRK DURMAZ H., SARI A., ARMAĞAN B., ERDEN A., KILIÇ L., KARADAĞ Ö., et al.

American College of Rheumatology, ACR Convergence-2017, Amerika Birleşik Devletleri, 3 - 08 Kasım 2017, (Özet Bildiri)

120. Two Cases of Glutaric Aciduria Type 2: How to Differentiate from Inflammatory Myuopathies

KOCA M., ERDEN A., ARMAĞAN B., SARI A., KILIÇ L., AKDOĞAN A., et al.

International Internal Medicine Training Meetings- 10, 19 - 21 Mayıs 2017, (Tam Metin Bildiri)

121. Evaluation of asssociation between antiphospholipid antibodies or lupus anticoagulant positivity and severity of vascular involvement in takayasu arteritis patients

FIRAT E., ERDEN A., SARI A., ARMAĞAN B., KILIÇ L., KARADAĞ Ö., et al.

EULAR 2017 Abstracts Accepted for Publication, 14 - 17 Haziran 2017, (Tam Metin Bildiri)

122. Adherence of rheumatic patients to inh prophylaxis prescribed before biological treatment: hur-bio single center real life results

ŞEYHOĞLU E., UYAROĞLU O. A., ERDEN A., KILIÇ L., ARMAĞAN B., SARI A., et al.

EULAR- Annual European Congress of Rheumatology, 2017, İspanya, 14 - 17 Haziran 2017, (Özet Bildiri)

123. Thorax ct findings in a large cohort of patients with rheumatoid arthritis: hur-bio real life results

SARI A., ARMAĞAN B., ERDEN A., KILIÇ L., KARADAĞ Ö., AKDOĞAN A., et al.

EULAR- Annual European Congress of Rheumatology, 2017, Madrid, İspanya, 14 Haziran 2017, (Özet Bildiri)

124. Biological therapy in non-systemic juvenile idiopathic arthritis patients followed in adult rheumatology department: hur-bio real life results

KILIÇ L., SARI A., ARMAĞAN B., ERDEN A., KARADAĞ Ö., APRAŞ BİLGEN Ş. Ş., et al.

EULAR 2017 ANNUAL MEETING, İspanya, 14 Haziran 2017, (Özet Bildiri)

125. Distribution of vasculitides in Eastern mediteranean: Results of a prospective cohort

KARADAĞ Ö., ERDEN A., BATU E. D., BİLGİN E., uyaroglu o., ŞEYHOĞLU E., et al.

EUROPEAN LEAGUE AGAİNST RHEUMATOLOGY ANNUAL MEETİNG 2017, 14 - 17 Haziran 2017, (Tam Metin Bildiri)

126. WIDE HETEROGENEITY IN TREATMENT PROTOCOLS AND INAPPROPIATE USE OF PREDNISOLONE FOR ANTI-RO/LA ASSOCIATED-CONGENITAL HEART BLOCK: A SYSTEMATIC REVIEW OF 492 CASES

ERDEN A., KILIÇ L., BİLGİN E., FANOURİAKİS A., CEYLAN S., HYMABACCUS B., et al.

EULAR- Annual European Congress of Rheumatology, 2017, İspanya, 14 - 17 Haziran 2017, (Özet Bildiri)

127. Abatacept experience in biologic naive rheumatoid arthritis patients: hur-bio real life results

SARI A., ARMAĞAN B., KILIÇ L., ERDEN A., KARADAĞ Ö., AKDOĞAN A., et al.

EULAR- Annual European Congress of Rheumatology, 2017, Madrid, İspanya, 14 - 17 Haziran 2017, (Özet Bildiri)

128. PSORIASIS IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER

ERDEN A., BATU E. D., BİLGİN E., SÖNMEZ H. E., ŞEYHOĞLU E., DEMİR S., et al.

EULAR- Annual European Congress of Rheumatology, 2017, Madrid, İspanya, 14 - 17 Haziran 2017, (Özet Bildiri)

129. Ankylosing spondylitis patients with uveitis had better adalimumab retention rate: hur-bio real life results

ARMAĞAN B., SARI A., ERDEN A., KILIÇ L., GÜVEN D. C., Pashayev T., et al.

EULAR- Annual European Congress of Rheumatology, 2017, Madrid, İspanya, 14 - 17 Haziran 2017, (Özet Bildiri)

130. Are the demographic and clinical features of polyarteritis nodosa similar between the uk and turkey?

KARADAĞ Ö., ERDEN A., BATU E. D., GOPALUNI S., SARI A., ARMAĞAN B., et al.

EULAR 2017 ANNUAL MEETING, İspanya, 14 - 17 Haziran 2017, (Özet Bildiri)

131. The use of rituximab in patients with rheumatoid arthritis: in which infusion intervals were given and how did they respond? HUR-BIO real life results

SARI A., GÜVEN D. C., ARMAĞAN B., KILIÇ L., ERDEN A., AKDOĞAN A.

EULAR- Annual European Congress of Rheumatology, 2017, İspanya, 14 - 17 Haziran 2017, (Özet Bildiri)

132. AB1198-HPR Presentation of a new scale assessing the biopsychosocial aspects of healing properties in rheumatic patients

ÜNAL E., KISACIK P., ARIN G., KARABULUT E., GÖKSÜLÜK D., VARDAR YAĞLI N., et al.

Abstracts Accepted for Publication ,EULAR2017, 14 - 17 Haziran 2017, (Özet Bildiri)

133. Premature coronary heart disease frequency in rheumatoid arthritis who are receiving biologic agents: hur-bio real life results

ARMAĞAN B., SARI A., ERDEN A., KILIÇ L., ERDAT E. C., KARADAĞ Ö., et al.

EULAR- Annual European Congress of Rheumatology, 2017, Madrid, İspanya, 14 - 17 Haziran 2017, (Özet Bildiri)

134. There is a communication problem between patient and physician during pre-conceptional period: hur-bio real life results

uyaroğlu o. a., şeyhoğlu e., ERDEN A., KILIÇ L., ARMAĞAN B., SARI A., et al.

EULAR- Annual European Congress of Rheumatology, 2017, İspanya, 12 - 15 Haziran 2017, cilt.76, ss.448, (Özet Bildiri)

135. BUDD-CHIARI SYNDROME IN BEHCET'S DISEASE: A RETROSPECTIVE MULTICENTER STUDY

Akyol L., Toz B., Bayindir O., Zengin O., Cansu D. U., Yigit M., et al.

Annual European Congress of Rheumatology, Madrid, İspanya, 14 - 17 Haziran 2017, cilt.76, ss.327-328, (Özet Bildiri)

136. IGG4-RELATED DISEASE IN EASTERN MEDITERRANEAN: CLINICAL FEATURES AND OUTCOMES OF A LARGE COHORT

KARADAĞ Ö., ERDEN A., AYHAN E. A., BÖLEK E. Ç., ARMAĞAN B., KILIÇ L., et al.

EULAR- Annual European Congress of Rheumatology, 2017, İspanya, 6 - 10 Haziran 2017, cilt.76, ss.720, (Özet Bildiri)

137. Comorbidity and Surgery History of Rheumatoid Arthritis Patients Who Receiving Biological Agent

ARMAĞAN B., SARI A., ERDEN A., KILIÇ L., KARADAĞ Ö., AKDOĞAN A., et al.

MIRCIM 2017 TIHUD-TIP JOINT MEETING, Krakow, Polonya, 11 - 14 Mayıs 2017, ss.24-25, (Özet Bildiri)

138. The Characteristic Features of the Patients with Deficiency of Adenosine Deaminase 2 (DADA2)

ERDEN A., BATU AKAL E. D., TAŞKIRAN Z. E., SÖNMEZ H. E., SARI A., ARMAĞAN B., et al.

2016 ACR/ARHP ANNUAL Meeting, 12 - 16 Kasım 2016, cilt.68, ss.1-4550, (Tam Metin Bildiri)

139. Biyolojik tedavi alan RA hastalarında RAID kompozit indeksinin değerlendirilmesi: HÜR-BİO gerçek yaşam verileri

ERDEN A., KILIÇ L., ARMAĞAN B., SARI A., AKDOĞAN A., APRAŞ BİLGEN Ş. Ş., et al.

17. ulusal romatoloji kongresi, Türkiye, 24 - 30 Ekim 2016, (Tam Metin Bildiri)

140. Dapsa with Twenty-Eight Joint Counts May Be Useful for The Assessment of Psoriatic Arthritis

KALYONCU U., BAYINDIR Ö., ÖKSÜZ M. F., KİMYON G., ERDEN A., YAVUZ Ş., et al.

2016 ACR/ARHP Annual Meeting, 12 - 16 Kasım 2018, cilt.75, ss.11592-1160, (Tam Metin Bildiri)

141. Demographic, Clinic and Laboratory Features of 755 Patients with Neonatal Lupus Erythematosus: Systematic Review

ERDEN A., KILIÇ L., BİLGİN E., CEYLAN S., Hymabaccus B., ŞENER Y. Z., et al.

Annual European Congress of Rheumatology (EULAR) June 2016, Londrina, Brezilya, 01 Haziran 2016, (Özet Bildiri)

142. DEMOGRAPHIC CHARACTERISTICS AND DISTRIBUTION OF THE VASCULITIDES FREQUENCIES: A REAL-LIFE EXPERIENCE OF VASCULITIS CENTER FROM EASTERN MEDITERRANEAN

KARADAĞ Ö., ERDEN A., BİLGİN E., BATU AKAL E. D., Armagan B., Sari A., et al.

Annual European Congress of Rheumatology (EULAR), London, Kanada, 8 - 11 Haziran 2016, cilt.75, ss.1096-1097, (Özet Bildiri)

143. SAT0357 Common and Uncommon Manifestations of Granulomatosis with Poliangiitis GPA at Chest CT A Vasculitis Center Experience

TAYDAŞ O., KILIÇ L., atçeken z., ERDEN A., ARMAĞAN B., SARI A., et al.

EULAR 2016, 8 - 11 Haziran 2016, cilt.75, ss.7962-796, (Özet Bildiri)

144. Ankilozan Spondilit ve aksiyel spondiloartritli hastalarda golimumab etkinliği: HÜR-BİO gerçek yaşam verileri sonuçları

ERDEN A., KILIÇ L., KARADAĞ Ö., ARMAĞAN B., AKDOĞAN A., KILIÇKAP S., et al.

XVI. Ulusal Romatoloji Kongresi, Türkiye, 28 Ekim - 01 Kasım 2015, ss.6, (Özet Bildiri)

145. BİYOLOJİK TEDAVİ ALAN RA HASTALARINDA ARTMIŞ MORTALİTE ORANI VARDIR: HUR-BİO GERÇEK YAŞAM VERİLERİ

ERDEN A., KALYONCU U., KILIÇ L., KARADAĞ Ö., BİLGİN E., BABAOĞLU H., et al.

XV. Ulusal Romatoloji Kongresi, Antalya, Türkiye, 29 Ekim - 02 Kasım 2014, (Özet Bildiri)

Kitaplar 13

1. Romatolojik Hastalıklarda Lenfadenopati ve Lenfoma

KARAKAŞ Ö., ERDEN A.

Romatoloji Pratiğinde Özellikli Hematolojik Konulara Tanısal Yaklaşım, ÜSKÜDAR CANSU DÖNDÜ, Editör, Ortadoğu Reklam Tanıtım Yayıncılık Turizm Eğitim İnşaat Sanayi ve Ticaret A.Ş./Türkiye Klinikleri Yayın Seri No- Türkiye Klinikleri Publication Serial Number : 1921, Ankara, ss.22-29, 2025

Metrikler

Yayın

404

Yayın (WoS)

207

Yayın (Scopus)

208

Atıf (WoS)

629

H-İndeks (WoS)

Atıf (Scopus)

1983

H-İndeks (Scopus)

Atıf (Scholar)

3162

H-İndeks (Scholar)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Sobiad)

H-İndeks (Sobiad)

Toplam Atıf Sayısı

707

Proje

Tez Danışmanlığı

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler